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ABSTRACT 
 
Influence of Nutrition during the Juvenile Period on Gene Expression within the 
Hypothalamic Arcuate Nucleus and on Age at Puberty in Heifers. (August 2010) 
Carolyn C. Allen, B.S., University of Connecticut 
Co-Chairs of Advisory Committee: Dr. Gary Williams 
         Dr. Marcel Amstalden 
 
 
 
 
 Developmental changes within the hypothalamus are necessary for maturation of 
the reproductive neuroendocrine axis.  Recent reports have implicated several neuronal 
networks in this process, but genes involved in their regulation have not been elucidated.  
Using a well-established model for nutritional induction of precocious puberty, 
objectives were to 1) use microarray technology to examine changes in gene expression 
within the arcuate nucleus (ARC) of the hypothalamus in pre-pubertal heifers fed high or 
low-concentrate diets, and 2) determine if high-concentrate diets are required for 
nutritional induction of precocious puberty.  In Experiment 1, early-weaned, cross-bred 
heifers were fed either a high-forage/low-gain (HF/LG; 0.45 kg/d) or a high-
concentrate/high-gain (HC/HG; 0.91 kg/d) diet for 91 d.  Analysis of microarray data 
indicated that 346 genes were differentially expressed (P < 0.05) between HC/HG and 
HF/LG heifers. Expression of three key metabolic genes [neuropeptide Y (NPY), agouti-
related protein (AGRP), and growth hormone receptor (GHR)] observed to be 
differentially expressed in the microarray analysis was investigated further by 
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quantitative PCR.  Real-time RT-PCR indicated that expression of NPY, AGRP and 
GHR was lower (P < 0.05) in HC/HG compared to HF/LG heifers. In contrast, 
concentrations of insulin (P < 0.05), IGF-1 (P < 0.002) and leptin (P = 0.1) were greater 
in HC/HG compared to HF/LG.  For Experiment 2, 48 heifers were used in 2 replicates 
(24 heifers/replicate) in a 2 x 2 factorial design to examine the roles of diet type (HF vs 
HC) and rate of gain (LG, 0.45 kg/d vs HG, 0.91 kg/d) on age at puberty. Heifers were 
fed HC/HG, HC/LG, HF/HG or HF/LG (n = 12/group) for 14 wk, and then switched to a 
common growth diet (0.68 kg/d) until puberty.  Heifers in both HG groups reached 
puberty at a younger age (54.5 ± 1.8 wk) than heifers in both LG groups (60.2 ± 1.9 wk; 
P < 0.04).  A marked increase (P < 0.01) in serum concentrations of leptin occurred in 
HC/HG heifers between 24 and 30 wk of age.  This increase in circulating leptin was not 
observed in other groups.  Overall, results indicate that nutritional regulation of 
reproductive neuroendocrine development involves the control of NPY, AGRP and GHR 
expression.  The abrupt increase noted for circulating leptin in heifers fed HC/HG diets, 
if timed and sustained appropriately, could represent an important temporal cue for 
activation of the neuroendocrine system and the onset of puberty.   
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NOMENCLATURE 
 
AGRP  Agouti-related protein 
AVPV  Anteroventral periventricular nucleus 
ARC  Arcuate nucleus 
FSH  Follicle-stimulating hormone 
DMH  Dorsomedial hypothalamus 
GnRH  Gonadotropin-releasing hormone 
GH  Growth hormone 
GHR  Growth hormone receptor 
ICV  Intracerebroventricular 
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MBH  Mediobasal hypothalamus 
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CHAPTER I 
 
INTRODUCTION 
 
Puberty is the consequence of developmental changes within the brain that lead 
to the attainment of reproductive capacity.  In the events leading up to the first ovulation, 
gonadotropin-releasing hormone (GnRH) released into the hypothalamic-hypophyseal 
portal circulation mediates secretion of luteinizing hormone (LH) from the anterior 
pituitary gland.  As maturation progresses, there is a decrease in hypothalamic sensitivity 
to estradiol negative feedback, which results in an increase in the pulsatile release of 
GnRH, and subsequently, LH.  These events lead to development of a dominant, 
estrogen-active follicle, increased concentrations of circulating estradiol, and ultimately 
the pre-ovulatory surge of LH and first ovulation [1].  In heifers, the luteal phase 
following the initial ovulatory surge of LH is usually associated with lower fertility 
compared to those that follow [2].  Consequently, it is helpful for beef heifers to become 
pubertal well in advance of first breeding in order to increase the probability of 
conception early in their first breeding season, and to maximize lifetime productivity [2-
4].  Puberty is a complex process and is dependent not only on the physiological changes 
directly related to the reproductive neuroendocrine axis, but also is influenced by a 
multitude of other cues emanating from the somatotropic axis and metabolism.  
 
 
___________ 
This thesis follows the style of Biology of Reproduction.  
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Although it is known that developmental changes within the hypothalamus 
underlie the processes driving the onset of puberty, the nature of these changes and the 
genes regulating them have not been elucidated. The hypothalamus plays a central role 
in the regulation of reproduction, and does this in part by integrating metabolic and 
reproductive signals within the arcuate nucleus (ARC).  The ARC, also known as the 
infundibular nucleus, is located in the mediobasal hypothalamus (MBH) adjacent to the 
third ventricle and median eminence (ME).  Neurons within the ARC are highly 
heterogeneous and project internally to act within the ARC, as well as projecting to other 
regions of the hypothalamus such as the ME [5] and pre-optic area (POA) [6], to act 
upon various other neurons.  Neurons expressing neuropeptide Y (NPY), agouti-related 
protein (AGRP), proopiomenalocortin (POMC), and cocaine- and amphetamine-
regulated transcript (CART) are of particular interest as they relate to the study of 
hypothalamic control of puberty. These neurons respond to local and peripheral 
metabolic signals and subsequently influence neuroendocrine events related to 
reproductive function [7].   
One currently accepted viewpoint is that a critical window exists during early 
calf-hood development in heifers during which sensitivity to dietary quality and quantity 
is heightened [8, 13-15].  As a result, dietary manipulations during this period can have a 
profound influence on the timing of puberty. Specifically, it is believed that increasing 
dietary energy intake hastens morphological and physiological changes in the 
hypothalamus, and allows neuroendocrine events imperative to attainment of puberty to 
occur at a younger age.  Conversely, restrictions to dietary energy intake delay the onset 
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of puberty [9, 10] and it is thought to delay the morphological and physiological events 
in the hypothalamus necessary for puberty to occur.  
 Ruminant and monogastric species derive dietary energy from ingested feedstuff 
via different mechanisms.  All mammalian species require adequate blood glucose 
concentrations for survival.  However, unlike monogastric species, ruminants do not 
depend entirely on glucose absorption in the small intestine to maintain blood 
concentrations of glucose for normal bodily function, but rather depend primarily on 
utilization of volatile fatty acids (VFA).  Volatile fatty acids are the end-products of 
anaerobic microbial fermentation, and are utilized by ruminants as the primary source of 
metabolizable energy [11].  Although acetate is produced in larger quantities in the 
rumen, it does not exhibit the gluconeogenic properties of propionate; thus in ruminants, 
propionate is the primary substrate utilized in gluconeogenesis [11, 12].  It is well 
documented [8, 13-16] that a combination of early-weaning and the feeding of high-
starch, propionate-favoring diets to pre-pubertal heifers results in a high incidence of 
precocious puberty.  In ruminants, an increased starch content of the diet would be 
expected to increase the ruminal propionate to acetate ratio, and to provide a greater 
amount of energy to the animal for immediate use, as well as for accumulation of body  
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mass during growth and development.  It is unknown if the reduction in age at puberty in  
heifers fed high-starch diets is due to the gluconeogenic nature of the diet, or if the same 
effect can be created with a high-forage, acetate favoring diet that promotes a similar 
rate of body weight gain.   
 The objectives of experiments described herein were to 1) examine gene 
expression within the ARC of the hypothalamus in pre-pubertal heifers fed diets 
previously shown to hasten or delay maturation of the reproductive neuroendocrine axis, 
and 2) to determine if propionate-favoring highly gluconeogenic diets are required for 
nutritional induction of precocious puberty.   
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CHAPTER II 
 
LITERATURE REVIEW 
 
Puberty in Heifers 
 Puberty is the consequence of a series of morphological and physiological 
changes that lead to the maturation of the hypothalamic-hypophyseal complex and 
reproductive capacity.  Fertility in beef heifers progressively increases from the first to 
third ovulation [2], so it is important to initiate reproductive cyclicity well in advance of 
the first breeding season in order to increase the probability of conception early in that 
breeding season.  This in turn maximizes lifetime productivity [2, 3].  The age at which 
heifers reach puberty can be affected by a variety of factors including body weight [17], 
age [18], subspecies [19], pre-weaning body weight gain [20], post-weaning body 
weight gain [21, 22], dietary restriction [23-25], and dietary intake [8, 13-16, 25]. 
 In order for puberty to occur, a disinhibition of the hypothalamic-hypophyseal 
complex through a decline in sensitivity to estradiol negative feedback must be realized.  
This results in increased secretion of GnRH, LH and follicle stimulating hormone (FSH), 
which will in turn stimulate the gonads and the initial ovulation.  Pre-pubertal heifers 
contain adequate stores of LH and FSH in the anterior pituitary gland to stimulate 
follicular growth and ovulation.  In response to stimulation of gonadotropes by repeated 
injections of GnRH, LH was released in a fashion similar to that observed directly before 
puberty [26].  Thus, adequate hypothalamic stimulation of the adenohypophysis to allow 
synthesis of the gonadotropins necessary for reproductive function is present well before 
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puberty. However, a lack of high-frequency pulses of GnRH appears to be the limiting 
factor for pubertal development [1].  During growth and development of prepubertal 
heifers, circulating concentrations of LH increase from birth until 3 mo of age, after 
which they decline until 6 mo of age [27].  Heifers exhibit a linear increase in 
concentrations of LH during the 5 mo period preceding puberty [1].  Frequency of LH 
pulses increases with a concomitant decline in pulse amplitude during the month before 
puberty [1, 27].  As noted earlier, as heifers progress towards puberty, sensitivity of the 
hypothalamus to estradiol negative feedback declines.  Research in sheep indicates that 
there is an increase in the frequency of GnRH pulses.  This promotes an increase in 
secretion of LH and FSH, and in follicular growth, which in turn stimulates increased 
secretion of estradiol. A peak in circulating estradiol ultimately stimulates a preovulatory 
surge of LH which results in ovulation [1].  It is unclear what causes the decline in 
sensitivity to estradiol; however, Day and co-workers have demonstrated a decline in the 
number of cytosolic estrogen receptors (ER) in the anterior hypothalamus, MBH and 
anterior pituitary gland during sexual maturation in heifers.  The number of ER in the 
POA and ME did not change during the same period of time [28].  Initially, it was 
thought that since GnRH neurons do not express estrogen receptor-alpha (ERα) [29], 
estradiol could mediate GnRH secretion indirectly; however, studies in mice [30], rats 
[29, 31, 32], sheep [33] and humans [34] have demonstrated the presence of estrogen 
receptor-beta (ERβ) in a subpopulation of GnRH neurons.  In cattle, GnRH perikarya are 
located primarily in the medial and lateral pre-optic areas [35], which according to the 
experiments by Day et al., did not exhibit a change in ER number during the pre-pubertal 
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period [28].  Collectively, these findings suggest that, although a decline in ER receptor 
number may be involved with the pre-pubertal decline in estradiol negative feedback, 
estradiol directly affects the GnRH neuronal system. 
 
Influence of Nutrition on Age at Puberty in Ruminants 
Appropriate nutritional balance is a prerequisite for allowing juvenile animals to 
proceed through pubertal development and to insure continuing reproductive capacity in 
adulthood.  In cattle, the onset of puberty can be hastened or delayed by modifying 
dietary energy intake [8, 13-16].  In particular, energy balance has been linked to sexual 
maturation of the hypothalamus through timing of a developmental decline in estradiol 
negative feedback [15].  It is well documented that both heifers and ewes subjected to 
restrictions in dietary energy intake reach puberty at an older age than those fed diets 
containing adequate energy content [9, 10].  Relatively low circulating concentrations of 
LH, a decreased frequency of LH pulses, and decreased responsiveness to GnRH have 
been demonstrated in heifers subjected to restrictions in dietary energy intake [36]. This 
phenomenon has also been demonstrated in sheep.  The frequency of GnRH pulses is 
reduced in growth-retarded lambs [37]; however, administration of hourly injections of 
the neurotransmitter N-Methyl-D, L-Aspartate (NMA), a GnRH secretagogue, results in 
the anterior pituitary gland secreting pulses of LH that are similar in size to those 
stimulated by physiological pulses of GnRH [38].  Additionally, adequate amounts of 
LH and FSH are present in the anterior pituitary of growth-retarded lambs as well as 
prepubertal heifers, and physiological doses of GnRH stimulate the release of 
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gonadotropins [39, 40].  These findings suggest that gonadotropin secretion is reduced, 
not because of a decrease in anterior pituitary function, but due to reduced secretion of 
GnRH.  This also indicates that animals must be in an appropriate energy balance for 
puberty to occur.  If a decrease in dietary energy intake delays the onset of puberty, it 
would be logical to speculate that an increase in dietary energy intake would hasten the 
onset of puberty.  Increasing energy intake has been shown to decrease the age at which 
puberty occurs in heifers.  Heifers weaned at 7 mo of age and fed a high starch diet 
starting at 60 d before onset of the breeding season reached puberty at slightly younger 
ages than heifers fed a high starch diet starting 30 d before the breeding season [16].  
This implies that increasing energy balance in heifers earlier in life is more effective at 
stimulating the onset of puberty than later in life.  Heifers weaned early, and 
subsequently fed a high concentrate diet until puberty, had a high incidence of 
precocious puberty, while early-weaned heifers fed a low-energy diet did not exhibit 
precocious puberty.  Additionally, heifers weaned at 3 mo of age and fed a high 
concentrate diet from 126-196 d of age to gain body weight at a high rate, or weaned at 3 
mo of age and fed a high concentrate diet from 126 d of age until puberty was reached, 
had a high incidence of precocious puberty.  Interestingly, heifers fed a low concentrate 
diet from 126 d of age and then switched to a high concentrate diet on day 196 had a low 
incidence of precocious puberty.  This indicates that both rate of gain and timing of the 
gain are important factors in stimulating the earlier onset of puberty, and suggests that 
neuroendocrine mechanisms modified by dietary energy intake are occurring before 6 
mo of age [8].  Precocious puberty induced by earlier weaning and feeding of a high-
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concentrate diet is associated with an enhanced secretion of LH, similar to that observed 
in older heifers developed on normal-growth diets.  This indicates that mechanisms 
underlying precocious puberty are comparable to those described in heifers that reach 
puberty at a more conventional age but are functioning at a much earlier age [13-15]. 
 
Influence of Nutrition on Follicular Growth 
Heifers weaned early and fed a high concentrate diet also demonstrated increased 
follicular development [14].  Follicle stimulating hormone and LH secreted from the 
anterior pituitary gland are the primary gonadotropins associated with follicular growth 
[41] and act on the granulosa and theca cells, respectively, of the growing follicle to 
stimulate folliculogenesis and steroid hormone production.  Estradiol synthesis requires 
an androgen precursor; however, granulosa cells lack the ability to convert cholesterol to 
androgens.  Theca cells convert cholesterol to androgens under the influence of LH, and 
granulosa cells aromatize androgens to estradiol via FSH-mediated aromatase activity 
[42].  Ovarian follicles have been observed in heifers as young as 2 wk of age, but they 
lack the ability to spontaneously ovulate and form corpora lutea.  The number of small 
and medium follicles increases steadily from 2 to 14 wk of age, then remains static until 
heifers reach approximately 8 mo of age.  The number of large follicles has been 
observed to increase steadily from 2 wk of age until approximately 8 mo of age.  Neither 
growth nor regression rate of follicles changed as heifers matured [43].  In prepubertal 
heifers, there is a rapid increase in follicular growth during the first mo after onset of a 
high energy diet [44] and dominant follicle diameter was larger in animals with greater 
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dietary energy intake than heifers of the same age with a lesser intake of dietary energy 
[45].  Heifers weaned early and fed a high-concentrate diet exhibited an increase in 
maximum follicle diameter compared to control-fed heifers [14].  Heifers exhibiting 
precocious puberty had greater dominant follicle diameters and longer follicular waves 
then heifers that did not reach precocious puberty.  Although dominant follicle diameter 
was increased at a younger age in heifers that reached precocious puberty, the number of 
follicles was decreased [15].  This relates to the observation of an increasing number of 
follicles between 2 wk of age to approximately 4-6 mo, followed by a decrease in 
number until puberty [14, 46].  In the foregoing experiments, serum estradiol did not 
differ at 126 d of age between heifers that eventually did or did not exhibit precocious 
puberty.  However, serum estradiol concentrations started to increase earlier in heifers 
reaching precocious puberty [15], and this was related to the coincident increase in the 
frequency of LH pulses [14]. 
The Arcuate Nucleus 
 The hypothalamus is essential for regulation of appetite and energy balance, as 
well as being the central modulator of reproductive function.  Within the hypothalamus, 
there are vast numbers of neuronal populations located in various nuclei that function 
alone as well as in a synergistic manner to integrate local and peripheral signals.  In 
particular, the ARC plays a vital role in integration of metabolic and neuroendocrine 
signaling pathways.  The two primary neuronal populations within the ARC that respond 
directly to metabolic cues result in opposite responses.  A subpopulation of neurons in 
the ARC co-express NPY and AGRP, both of which are orexigenic neurotransmitters that 
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respond during times of low energy balance and stimulate appetite and feeding behavior 
[47, 48].  The second subpopulation of neurons in the ARC co-express POMC and 
CART, both of which are anorectic compounds that respond to signals of excess energy 
by suppressing appetite and feeding behaviors.  The ARC is conveniently located close 
to the ME, which has a compromised blood brain barrier and allows for the 
hypothalamus to respond to various hormones in the peripheral circulation such as leptin 
and insulin.  Both NPY/AGRP and POMC/CART neurons respond to leptin; however, 
they do so in opposing directions.  Although the ARC responds primarily to metabolic 
signaling, the neurons project outward to exert stimulatory or inhibitory effects on 
various other nuclei of the hypothalamus to maintain energy homeostasis, as well as to 
modulate reproductive function.  For example, NPY/AGRP neurons project from the 
ARC to GnRH perikarya and fibers in the POA and the ME [5] and in response to 
peripheral and local metabolic signaling, mediate release of GnRH [49].  There is 
thought to be a critical window of growth and development during early calf-hood that 
predetermines the age at which heifers become pubertal.  It is believed that modifying 
calf-hood nutrition during that critical period will positively or negatively influence the 
age at which puberty is reached [8].  It is also thought that the ARC will respond to 
modifications in nutrition during the proposed “critical window” and aid in hastening 
maturation of the reproductive axis.   
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Roles of Signaling Peptides in Pubertal Development and Energy Homeostasis 
Onset of puberty and energy homeostasis are influenced by various metabolic 
hormones, growth factors, neuropeptides, and neurotransmitters including leptin, insulin, 
insulin-like growth factor-1 (IGF-1), NPY, AGRP, POMC, and kisspeptin.  
Leptin 
 Leptin is a potent satiety hormone synthesized from the LEP gene, reflects body-
fat mass, influences energy intake and expenditure, and integrates metabolic signaling 
with reproductive function.  Leptin is secreted primarily by white adipocytes; however, 
it has also been found to be secreted from the various other cell types in the placenta 
[50], stomach [51], and pituitary [52].  The leptin receptor (LEPR) is structurally similar 
to other cytokine receptors [53, 54] and functions via janus-kinase (JAK)/STAT (signal 
transducers and activators of transcription), mitogen-activated protein kinase (MAPK), 
and phosphatidylinositol 3-kinase (PI3K) pathway activation [55, 57].  Due to alternative 
splicing of the leptin receptor gene (LEPR), there are at least 5 different isoforms of the 
leptin receptor including one long form, and several short forms [58, 59].  The 
extracellular and transmembrane domains are identical; however, the number of 
cytoplasmic amino acid residues differs between isoforms [58].  The long form of the 
receptor is expressed in high abundance within the hypothalamus, specifically in the 
ventromedial hypothalamus (VMH) [60-62] and the ARC [61, 62].  In the VMH, leptin 
receptor is differentially expressed depending on energy state.  Dyer and co-workers 
found that in the VMH and ARC, leptin receptor is expressed in greater abundance in 
ovariectomized adult ewes subjected to feed restriction than in well-fed ovariectomized 
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adult ewes [61].  Similar results were found in feed-restricted wethers compared to 
normally-fed wethers; however, differences in leptin receptor gene expression were 
observed only in the ARC and not the VMH [63]. The long form of the leptin receptor is 
also expressed in the lung, kidney, liver, adipose tissue, and pancreatic β-cells [59, 64].  
Within the hypothalamus, leptin plays an important role in the integration of 
metabolic signaling and reproductive function.  Leptin appears to communicate 
nutritional status to specific regions of the hypothalamus including whether energy 
balance is sufficient for initiation/continuation of reproductive function via interactions 
with various neuronal populations.  Furthermore, leptin is necessary for maintaining 
normal body weight.  Individuals exhibiting homozygous mutations of the leptin gene 
are obese and lack the ability to reproduce [65, 66].  In mice with mutations for Lep 
(ob/ob), leptin is absent and results in obesity [65] and impaired reproductive function in 
both males and females [66].  Although male ob/ob mice are able to gain reproductive 
function by reducing body weight through energy restriction [67], females lack the 
ability to do so.  Interestingly, sterility is reversed in female ob/ob mice treated with 
leptin, and ovulation, pregnancy and parturition are able to occur [66] through activation 
of the hypothalamic-hypophyseal axis [68].  Since treatment with leptin allows for 
normal reproductive function to occur, it was thought that perhaps leptin plays an 
imperative role in the initiation of puberty through maturation of the hypothalamic-
hypophyseal complex.  Although prepubertal heifers exhibit a steady linear increase in 
serum leptin as puberty approaches [69], leptin alone does not accelerate the maturation 
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of the hypothalamic-hypophyseal complex in heifers [70] or rats [71].  However, leptin 
is believed to have a permissive effect on the initiation of puberty.    
Neuroendocrine responses to leptin differ depending on nutritional balance and 
reproductive status.  During the peripubertal period, heifers are highly sensitive to short-
term energy restriction as reflected by decreased frequency of LH pulses, and decreased 
concentrations of insulin and IGF-1 [72].  However, subcutaneous treatment with leptin 
prevents fasting-induced reductions in frequency of LH pulses, not only in peripubertal 
heifers [73], but also in rats [74] and wethers [75].  In contrast, LH pulse frequency is 
not affected by short-term fasting in mature cows.  Short-term fasting causes a decrease 
in mean concentrations of leptin and leptin mRNA in mature cattle [76]; however, 
treatment with leptin stimulates an increase in GnRH secretion into third ventricle 
cerebral spinal fluid [70], and increases mean concentrations and pulse amplitude of LH 
in cattle [76] and sheep [75].  Treatment with exogenous leptin does not elicit the same 
effect in full fed sheep and cattle.  In fact, central infusion of leptin had no effect on 
mean concentration, or the frequency or amplitude of pulses of LH in well-nourished 
sheep [75, 77] or cattle [76].   
Neuropeptide Y and leptin receptor mRNAs are co-expressed in neurons within 
the ARC [78], suggesting that leptin directly regulates NPY.  In fact, it appears that 
leptin negatively regulates NPY [79].  In diabetic rats, NPY expression within the ARC 
was increased; however, once insulin concentrations were corrected, concentrations of 
leptin increased rapidly, NPY expression was greatly reduced, and reproductive function 
resumed.  Additionally, NPY mRNA expression is increased in fasted rats, but is 
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reduced following treatment with leptin.  Interestingly, NPY mRNA expression in the 
ARC is also reduced when normally fed rats are treated with leptin [71].  These findings 
are interpreted to indicate that leptin has a direct inhibitory effect on NPY neurons, and 
that suppression of NPY allows for release of GnRH and subsequent secretion of LH.  
Collectively, it appears that although leptin does not act as a trigger for the onset 
of puberty, its presence is required and acts passively during sexual development to 
activate and maintain function of the reproductive neuroendocrine axis, possibly through 
a reduction of NPY inhibitory tone on GnRH neurons.   
Insulin-like Growth Factor-1 
  Insulin-like growth factor-1 is a 70 amino acid, single-chain peptide that is 
linked to somatic growth, glucose metabolism, and survival, proliferation and 
differentiation of a variety of cell types [80].  In prepubertal heifers, concentrations of 
serum IGF-1 vary greatly depending on breed, diet, and rate of gain.  Crossbred Bos 
taurus heifers fed a diet formulated to promote a high rate of gain exhibited greater 
serum concentrations of IGF-1 in the 10 weeks prior to puberty than heifers fed a diet 
formulated to promote a low rate of gain.  As the low gain heifers approached puberty, 
serum IGF-1increased to concentrations similar to high gain heifers which could be 
attributed to the increase in nutrient intake during the 4 weeks prior to initiation of 
puberty [25].  Crossbred Bos indicus-influenced heifers fed a high concentrate diet had 
greater serum concentrations of IGF-1 than heifers fed a high fat diet; however both 
groups demonstrated a decrease in concentrations as puberty approached [81].  
Prepubertal bulls fed a diet designed to yield a moderate rate of gain exhibited an 
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increase in IGF-1 and a decrease in IGF-1 binding protein-2 (IGFBP-2) as they 
approached puberty.  In contrast, bulls fed a restricted-energy diet exhibited a delayed 
rise in IGF-1 and an increased concentration of IGFBP-2 [82].  These findings agree 
with previous research in prepubertal heifers [25, 81], young steers [83], and young bulls 
[84], and indicate that IGF-1 is influenced by nutrient intake.  Secretion of GnRH from 
isolated ME of the hypothalamus is induced by exposure to IGF-1 [85].  In studies 
conducted in juvenile rats, third ventricle injections of IGF-1 were capable of stimulating 
a release of LH, while third ventricle administration of GnRH antiserum plus IGF-1 
blocked the pituitary response to IGF-1 [86].  It is believed that IGF-1 does not act 
directly on GnRH neurons [87], but acts via glial intermediate pathways since glial cells 
in the ME contain IGF-1 receptor (IGF-1R) mRNA [88, 89].   
Neuropeptide Y 
 Neuropeptide Y is a 36-amino acid orexigenic neurotransmitter involved in food 
intake, thermoregulation, and reproductive function [90, 91].  Although widely 
distributed throughout the peripheral and central nervous system (CNS), NPY is 
expressed in the greatest abundance in the hypothalamus, particularly in the ARC.  Since 
NPY neurons project from the ARC to the ME where they are in close proximity to 
GnRH fibers [5] as well as with GnRH neurons in the POA [6] it appears that NPY has a 
dual regulatory effect on GnRH neurons in response to local and peripheral metabolic 
signaling.  The effects of NPY are mediated by six receptor subtypes and are denoted 
Y1-Y5 and y6 [92-94].  The Y receptor subtypes belong to the G protein-coupled receptor 
superfamily and inhibit adenylyl cyclase [95, 96].  Subtypes Y1, Y2 and Y5 preferentially 
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bind NPY and peptide YY (PYY) [92]; however, Y1 and Y5 appear to be largely 
involved with metabolic and reproductive functions.  The Y1 subtype is highly conserved 
between Xenopus laevis and mammals [92], and has been localized in the brain, heart, 
kidney and gastrointestinal tract of humans, rats and mice [97-99].  It appears that the Y1 
receptor is a key regulator of GnRH release and feeding behavior.  Intact female pre-
pubertal rats exhibited a significant increase in release of LH when the Y1 receptor 
antagonist was administered intracerebroventricular (icv) [93].  Castrated male rhesus 
monkeys also exhibited an immediate release of LH following Y1 receptor blockade 
[100].  Gonzales and co-workers [101] studied NPY inhibition of the reproductive axis 
during poor nutritional balance, and in particular the involvement of the Y1 receptor.  
They utilized both male and female Y1 knock-out (Y1-/-) mice fed either restricted or ad 
libitum diets, and examined food intake, body-weight gain, and the onset of puberty.  
They found that Y1-/- mice were lighter than wild-type (Y1+/+) mice at weaning. There 
were no differences in age at puberty between full-fed Y1 wild-type and Y1-/- mice; in 
contrast, onset of puberty was significantly delayed in feed-restricted Y1+/+ mice as 
compared to feed-restricted Y1-/-.  Circulating concentrations of LH was also greatly 
reduced in feed-restricted Y1 wild-type compared to full-fed Y1 wild-type mice.  These 
results were interpreted to indicate that the NPY Y1 receptor is vital in sensing metabolic 
conditions by the hypothalamic-hypophyseal axis, and that Y1 is a key mediator of the 
effects of NPY on reproductive function [101].  As mentioned previously, the Y1 
receptor subtype is not the only mediator of NPY effects on reproductive function.  The 
Y5 receptor subtype also appears to integrate NPY signaling and reproductive function. 
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In fact, the Y5 receptor subtype has been found on GnRH neurons in the POA [6] and it 
appears to not only mediate NPY-stimulated feeding behavior, but also modulates 
release of GnRH [49].  
Hypothalamic NPY is responsive to metabolic hormones, such as leptin and 
insulin. This is reflected during changes in metabolic state by increases in NPY mRNA 
expression and peptide release during fasting or undernourishment, and by decreases 
after feeding or during positive energy balance [7].  Within the ARC, mRNAs for NPY 
and leptin receptor (LEPR) are co-expressed [78, 102]. Additionally, concentrations of 
NPY, NPY mRNA [103] and feed intake were reduced [71] with leptin treatment.  This 
indicates that leptin has a direct regulatory effect on NPY.  Insulin undoubtedly regulates 
NPY as well but, since it is unclear if NPY neurons express insulin receptor (INSR), it is 
possible that this regulation occurs through an indirect pathway.  Cultured murine 
hypothalamic tissue sections treated with estradiol for 24 h displayed a significant 
decrease in both NPY and AGRP mRNA expression, indicating that estradiol exerts an 
inhibitory effect on NPY/AGRP neurons.   However, since NPY/AGRP neurons in the 
mouse do not express estrogen receptor-α (ERα), it is possible that estradiol exerts its 
inhibitory effects indirectly [79].  
It is evident that reproductive function is directly correlated with metabolic state 
since sexual maturation is delayed [104] and reproductive function is stalled when 
metabolic conditions are not adequate.  Hypothalamic NPY is important, not only for its 
involvement in regulation of food intake and appetite in response to energy balance, but 
also for integration of metabolic and reproductive signaling and control of the 
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reproductive neuroendocrine axis. Hypothalamic NPY has been reported to have both 
stimulatory and inhibitory effects on reproductive function depending on species, 
physiological state, duration of exposure (e.g. chronic or acute exposure), and steroid 
hormone environment.  
Chronic infusion of NPY into the lateral ventricle of the brain disrupts 
reproductive cyclicity in intact adult female rats, and compromises reproductive ability 
in intact male rats [91, 105].  Intact juvenile female rats, chronically exposed to NPY 
exhibit delayed sexual maturation [105].   
In contrast, a single dose of exogenous NPY administered icv to pre-pubertal 
female rats stimulated precocious puberty [106].  This could be via a mechanism similar 
to that observed in earlier studies that reported a simultaneous surge of GnRH/NPY the 
day prior to vaginal opening in intact juvenile female rats [107].  Neuropeptide Y 
expression patterns within the hypothalamus and POA in intact growing female rats 
mimicked the expression patterns of GnRH in the same areas [107].   
Release of GnRH and LH was inhibited or reduced in ovariectomized (OVX) 
ewe lambs [108, 109], rhesus monkeys [110], and rabbits [111] treated icv with 
exogenous NPY which indicates an inhibitory effect of NPY in the absence of gonadal 
steroids.  In contrast, estradiol treated OVX rats and rabbits exhibited a transient increase 
in release of GnRH and LH when administered exogenous NPY icv [112, 113].  
However, these observations were restricted to rats and rabbits, since estradiol-treated 
OVX rhesus monkeys did not display any change in mean concentration, pulse 
frequency, or pulse amplitude of LH when treated with NPY [114], Moreover, OVX ewe 
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lambs treated with estradiol exhibited a reduction in release of GnRH and LH following 
icv administration of NPY [108].  In cattle, NPY appears to play an inhibitory role in 
both OVX and OVX estradiol-treated cows as both exhibited a reduction in mean 
concentrations of LH following icv administration of exogenous NPY [115, 116].  
Neuropeptide Y expression patterns have not yet been characterized in prepubertal 
heifers. 
Agouti-related Protein and the Hypothalamic Melanocortin System 
 Agouti-related protein and POMC, in concert with NPY, regulate energy 
homeostasis through intricate signaling mechanisms in response to metabolic hormones 
(e.g. insulin) and various signals from adipose tissue (e.g. leptin) and the gastrointestinal 
tract (e.g. cholecystokinin) [117].  Agouti-related protein is a small orexigenic peptide 
found primarily in the hypothalamus and adrenal gland [118, 119]; however, it is found 
less abundantly in the subthalamic nucleus, testis and lung [118].  Within the 
hypothalamus, AGRP expression is restricted to the ARC and the inner palisade zone of 
the ME.  In humans there appears to be several splice variants of AGRP; the larger 
transcript is localized in the hypothalamus, while the smaller transcript is expressed in 
the peripheral tissues [118].  Hypothalamic POMC is a large anorexigenic polypeptide 
precursor synthesized primarily in the ARC [35] and is involved in regulation of energy 
homeostasis [119].  Although the mature form of POMC is biologically inactive, during 
posttranslational processing it is cleaved into several biologically active peptides 
including adrenocorticotropic hormone (ACTH), α- β- and γ-melanocortin-stimulating 
hormones (α-MSH, β-MSH and γ-MSH, respectively), and the endogenous opioid β-
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endorphin.  Tung and co-workers conducted elaborate studies with Pomc knock-out 
mice (Pomc-/-) to determine the effects of melanocortins on food intake and body weight.  
By icv administration of α-, β-, γ-MSH to Pomc-/- mice and subsequent evaluation of 
food intake, body weight gain, and fat and lean body mass, it was determined that α-
MSH is the primary POMC derivative involved in food intake and energy homeostasis 
[121].  These findings are in agreement with previous research demonstrating significant 
weight loss in Pomc-null mice subjected to treatment with a stable α-MSH agonist [119].  
Melanocortins mediate their effects via 7-transmembrane domain G-coupled protein 
receptors located on various neurons in the hypothalamus.  Although five different 
subtypes of the melanocortin receptors exist (MC-R), only melanocortin 3 receptor 
(MC3R) and melanocortin 4 receptor (MC4R) are expressed in the hypothalamus, both 
which bind α-MSH [122].  Interestingly, AGRP binds to the MC-R with high affinity 
and blocks the actions of α-MSH [119].   
 During times of adequate energy balance, α-MSH is released from POMC 
neurons and subsequently binds to the MC4R on secondary neuronal populations, 
primarily in the paraventricular nucleus (PVN).  Activation of the MC4R leads to 
decreased food intake and increased use of energy [123].  Conversely, AGRP selectively 
antagonizes MC3R and MC4R [119] and blocks the anorexigenic effects of α-MSH.  
Concurrent with the antagonistic actions of AGRP on MC3R and MC4R, NPY exerts 
orexigenic effects via the aforementioned Y receptors on various secondary neuronal 
populations.   Collectively, in an effort to increase energy balance, the combined actions 
of AGRP and NPY lead to an increase in appetite.  Neurons expressing AGRP/NPY and 
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those expressing POMC/CART mediate energy homeostasis by responding to a plethora 
of metabolic signals.  They are regulated primarily by leptin and insulin; however, they 
respond to glucose, fatty acids, and various other nutrients as well.  Leptin signaling 
from adipose tissue is reflective of energy stores and inhibits AGRP neurons, while 
stimulating POMC neurons.  Activation of the LEPR triggers the JAK/STAT second 
messenger signaling pathway and subsequent phosphorylation, activation and nuclear 
translocation of the signal transducer and activator of transcription 3 (STAT3) in both 
neuronal populations.  Following nuclear translocation, STAT3 binds to the promoter 
region of both genes.  However, binding to POMC causes recruitment of histone 
acetylases, increases transcription and subsequent protein synthesis, while binding to 
AGRP causes recruitment of histone deacetylases and decreases mRNA and protein 
synthesis [123].  This transcriptional regulation of POMC and AGRP by leptin is 
imperative for attaining and maintaining adequate energy stores.  Additionally, both 
leptin and insulin mediate cellular function in AGRP and POMC neurons via the PI3K 
signaling cascade, and ATP-dependent potassium channels [123].   
 As previously mentioned, the majority of AGRP neurons co-express NPY and 
project from the ARC to the PVN and POA [47].  Studies in OVX rats [124] and rhesus 
monkeys [125] suggest an inhibitory role of AGRP on secretion of GnRH, and 
subsequent gonadotropin secretion.  Schioth and co-workers demonstrated in OVX 
steroid-primed rats that central administration of human AGRP completely abolished the 
surge of LH [124].  Furthermore, continuous icv administration of human AGRP to 
OVX adult rhesus monkeys results in suppression of LH pulses, and decreased 
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concentrations of LH [125].  Conversely, central administration of AGRP to intact male 
rats causes an increase in GnRH and gonadotropin secretion, suggesting that the actions 
of AGRP at the level of the hypothalamus are sexually dimorphic [126].  Additionally, 
AGRP had no effect on gonadotropin secretion in cultured pituitary cells.  This suggests 
that AGRP regulates gonadotropin secretion via mediation of GnRH neurons [126].  
However, although MC4R is expressed in the ARC, PVN, medial POA [127] and 
immortalized hypothalamic GT1-1 cells [128], it is unclear if melanocortin receptors are 
present on GnRH neurons.  Clearly, AGRP is vital in regulating GnRH secretion; 
however, it is unclear if AGRP directly or indirectly regulates GnRH neurons.   
Kisspeptin 
  Recent studies have suggested a role for the neuropeptide, kisspeptin in 
stimulating GnRH/LH release [129-131].  Kisspeptins are a neuropeptide family derived 
from the KISS1 gene.  The initial product of KISS1 is a 145-amino-acid peptide, which is 
cleaved into a 54-amino-acid peptide commonly known as kisspeptin-54. Three shorter 
peptides, kisspeptin-14, kisspeptin-13 [132] and kisspeptin-10 [133] have also been 
identified; all three are terminated by a common RF-amide motif and have a C-terminus 
identical to kisspeptin-54 that is involved mainly in ligand/receptor binding [132-134].   
Kiss1 is expressed in the placenta, testes, pancreas, liver, small intestine [134] 
and the brain [135-138].  Kiss1 mRNA has been localized to the ARC of the 
hypothalamus, an area of the hypothalamus important for regulation of GnRH secretion 
in mice [135, 139], rats [136, 140], primates [130, 137], hamsters [141], and female 
sheep [138, 142].  It is also expressed in the anteroventral periventricular nucleus 
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(AVPV) in mice and rats [135, 139-141], the periventricular nucleus (PeN) [139] and 
dorsomedial hypothalamus (DMH) in mice [143], and the POA and DMH in sheep [138, 
142, 144]. Kiss1 appears to be regulated primarily by gonadal steroids [136, 138, 139].  
In the absence of estradiol, Kiss1 mRNA in the ARC was greatly increased in ewes 
[138], female non-human primates and the human female [137].  In the presence of 
endogenous estradiol or estradiol replacement, abundance of Kiss1 mRNA in the ARC 
was decreased [137, 138].  However, estradiol exerts both positive and negative effects 
on Kiss1 neurons in rodents.  In the absence of estradiol due to ovariectomy, mice 
exhibit greater expression of Kiss1 mRNA in the ARC but decreased expression in the 
AVPV.  Estradiol replacement caused Kiss1 mRNA in the ARC to decrease, and Kiss1 
mRNA in the AVPV to increase [139].  This indicates a dual role for regulation by 
estradiol in the rodent brain.  Although many Kiss1 neurons express both ERα and ERβ 
[139, 140, 144], based on elaborate studies using ERα and ERβ knock-out mice, it is 
apparent that estradiol mediates its effects on Kiss1 neurons via ERα [139].  It also 
appears that Kiss1 is regulated by progesterone, but not the extent of regulation by 
estradiol [138].  
Evidence indicates that kisspeptin directly regulates secretion of GnRH [129, 
131, 135, 136].  Following ICV administration of kisspeptin, a subsequent release of LH 
has been detected in rats [136], mice, ewes [129] and primates [131].  Administration of 
a highly-specific GnRH antagonist prior to kisspeptin treatment abolished the 
aforementioned LH response [135].  This confirms that kisspeptin mediates the release 
of LH from the adenohypophysis by stimulating release of GnRH from the 
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hypothalamus.  The effects of kisspeptin are mediated by the kisspeptin receptor, GPR54 
[129], which is a G protein-coupled receptor similar to the galanin receptor [145].  It is 
highly conserved between rats and humans, differing greatly only in the C and N 
termini, and the third extracellular loop of the C-terminal intra-cellular domain [132].  
Messenger RNA for GPR54 is expressed in great abundance in a variety of organs and 
tissues including the pituitary, placenta, spinal cord, pancreas [132, 134] and 
hypothalamus [129, 136, 145].  The mRNA for GPR54 is found in lesser abundance in 
small intestine, thymus, spleen, lung, testis, kidney and liver [132].  Within the 
hypothalamus, GPR54 mRNA is expressed in GnRH neurons in the rat [136], rhesus 
monkey [146], and mouse [129].     
Recently, it has become apparent that kisspeptin/GPR54 signaling must be 
functional in order for normal sexual maturation to occur.  In normally-developing 
female primates, mRNA for both Kiss1 and GPR54 increase progressively from the 
juvenile to the pubertal periods [131].  Furthermore, humans [130, 147] and mice [130, 
148] with homozygous mutations in GPR54 did not attain normal puberty, displayed 
hypogonadotropic hypogonadism, and exhibited low concentrations of gonadotropins 
and gonadal steroids.  Interestingly in GPR54 knock-out (GPR54-/-) mice, adequate 
amounts of GnRH, LH and FSH were present, and injection of GnRH stimulated release 
of both LH and FSH from the anterior pituitary [130].  This indicates that normal 
anterior pituitary function is present, and that GPR54 is required to initiate and maintain 
normal sexual maturation at puberty.  However, all mutations in the GPR54 gene do not 
result in obliteration of sexual development.   In humans, a single point-mutation in the 
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GPR54 gene sequence can cause central (gonadotropin-dependent) precocious puberty 
[149].  Additionally, there is evidence that GPR54 expression is affected by nutritional 
restriction [150].   
Microarray Technology and Its Use in Neuroendocrine Research 
 Microarray technology has been utilized to examine the expression patterns of 
thousands of genes in various tissues and cells from a multitude of mammalian species.  
Many microarray platforms are somewhat costly and require special expertise to utilize; 
however, the ability to efficiently assess the expression profiles of a large number of 
genes in one assay has had a profound impact on neuroendocrine research. This has been 
particularly true for identification of hormonally-regulated genes expressed in the 
hypothalamus and pituitary gland that respond to changes in various physiological 
conditions [151, 152]. To maximize success with microarrays, it is essential that tissues 
or cells are properly harvested, and that RNA samples are appropriately extracted, are of 
high-quality, and are collected in enough quantity to detect changes in expression 
patterns between treatment groups.  The method by which tissue is collected prior to 
RNA extraction is usually determined by the type of tissue in question.  Homogeneous 
tissue is easily collected; however, many neuroendocrine tissues consist of highly 
heterogeneous cell populations.  In particular, it is difficult to harvest tissue from 
specific regions of the hypothalamus (e.g ARC), or to harvest a specific cell type (e.g. 
GnRH neuron) without contamination from adjacent regions (e.g. VMH) or surrounding 
cells [153].  In recent years, use of laser capture micro-dissection (LCM) technology has 
alleviated that problem since it allows for dissection of specific areas of tissue or specific 
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cell types.  In particular, LCM has been utilized in studies designed to identify and 
examine gene profiles in specific hypothalamic regions in the rat [154, 155], hamster 
[156], and mouse [157].  Although this is an exceptional tool, it is not a suitable option 
for all experiments since many LCM protocols require tissue to be sectioned at a 
thickness of no more than 10 µm (Ambion LCM staining protocol).  In cattle, many 
hypothalamic cell types exceed 10 µm and sectioning tissue at that thickness will result 
in fragmentation of the cellular membrane and subsequent loss of cell content.  Another 
method for extracting tissue is to collect a punch sample; however, in some species it is 
difficult to validate the exact location the sample was taken from.  In addition, this 
approach is not optimal for experiments that require precise isolation of specific cell 
types or tissues, and it is apparent that other methods must be developed to successfully 
harvest uncontaminated tissue and cells from specific regions of the bovine 
hypothalamus.  In addition to appropriate tissue extraction, microarray technology is 
optimized with high-quality RNA samples.  To maximize RNA quality, selection of an 
appropriate extraction method is a critical step.  The method used for RNA extraction 
depends on the type of sample (i.e. cells or tissue) and how much sample is available.  
Total cellular RNA is often isolated by using a methodology that incorporates a reagent 
containing phenol and guanidine isothiocyanate which work to maintain the integrity of 
the RNA, while breaking down cell walls to release cellular content.  This method is 
widely used; however, it may not be optimal for all experiments, especially in those 
lacking a large quantity of sample tissue.  Several commercially-available RNA isolation 
kits have been used to prepare samples prior to microarray analysis. A variety of studies 
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have been conducted to examine the commercially-available RNA extraction kit that 
yields the largest amount and highest quality RNA from both whole tissue and cells.  In 
studies involving bovine blood and whole tissue to compare total yield and quality of 
RNA between several extraction kits, it was found that although the TRIzol (Invitrogen) 
extraction kit produced the greatest yield of RNA, the RNAqueous kit (Ambion) 
produced RNA of the greatest quality [158].  Similar conclusions were deduced from 
studies utilizing cultured cells; however, it was found that although the TRIzol method 
produced the greatest yield, samples were contaminated by proteins and genomic DNA 
[159].  The presence of both proteins and genomic DNA are unfavorable in RNA 
samples that are to be used in microarray experiments.  Following extraction, RNA 
integrity must be confirmed.  A simple method to determine RNA quality is to obtain 
260/280 absorbance ratios from a spectrophotometer which indicates possible RNA 
degradation and chemical or genomic DNA contamination.  However, for use in highly 
sensitive microarray experiments, it is more favorable to measure RNA quality using a 
chip-based assay such as the Bioanalyser 2100 (Agilent Technologies, Inc., Palo Alto, 
CA, USA).  This assay has been utilized extensively to confirm RNA integrity prior to 
microarray analysis [159, 160].  Finally, the type of microarray must be determined.  
Usually microarray samples are labeled with two fluorophores, however, up to four can 
be used.  One drawback of utilizing two and four color arrays is that fluorophore uptake 
by the samples is not equal, and differences in fluorophore intensity during analysis must 
be taken into consideration.  A simple solution is to use a dye-swap array design.  In a 
dye-swap array, an equal amount of sample is labeled with each color and hybridized 
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accordingly so that any “dye bias” is compensated for.  Currently there are no previous 
reports of utilizing a dye-swap technique to examine differential gene expression within 
the ARC of the hypothalamus in cattle, although a bovine oligo microarray is 
commercially available (Agilent Technologies, Santa Clara, CA).   
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CHAPTER III 
 
GENE EXPRESSION IN THE ARCUATE NUCLEUS OF HEIFERS IS 
AFFECTED BY CONTROLLED INTAKE OF HIGH- AND LOW-
CONCENTRATE DIETS 
 
Introduction 
 Age at onset of puberty is largely dependent upon rate of growth during the 
prepubertal period.  Nutrient restriction during postnatal development delays puberty [9-
10] by inhibiting the release of GnRH [37].  Many factors have been implicated in 
signaling nutritional status to the control of reproduction, including hormones (insulin 
[161], IGF-1 [25, 85], GH [162] and leptin [81], and nutrients (glucose [161] and fatty 
acids [81]). These signals are believed to act on the hypothalamus to control various 
neuroendocrine functions, including the regulation of GnRH release [86, 70].  Major 
metabolic-sensing neurons are located within the arcuate nucleus of the hypothalamus 
and include NPY/AgRP neurons [47, 48].  Both are responsive to changes in nutrient 
status [7, 102] and appear to play a major role in mediating the effects of nutrition on 
reproductive function [49]. However, a host of complex interactions involving neuronal 
and glial networks influence this system [163].  The development of microarray 
technology and computational methods to analyze data derived from high-throughput 
approaches provide an opportunity to investigate these complex networks and the 
pathways that integrate the nutritional regulation of pubertal development. 
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 In maturing heifers, accelerated growth during early calf-hood has a major 
influence on age at puberty.  Heifers weaned at 3 mo of age and fed diets that promote 
high rates of body weight gain between 3 and 7 mo of age reach puberty much earlier 
and at lower body weight than heifers fed diets to gain weight at a lower rate during the 
same period [8, 13-15].  Elevated body weight gain later during calf-hood does not seem 
to have such impact.  Therefore, a critical window for nutritional imprinting of 
neuroendocrine functions that regulate age at onset of puberty seems to exist early in 
development.  We propose that this imprinting is a result of functional changes in 
neuronal networks that integrate energy expenditure and reproductive function.  In the 
studies reported herein, early-weaned heifers fed diets that promote markedly differing 
weight gains during early calf-hood were used to examine the expression of genes that 
are differentially responsive to nutritional inputs.  We investigated changes in gene 
expression in the arcuate nucleus because this region of the hypothalamus is an area 
populated by important metabolic-sensing neurons [47, 48], as well as neurons 
implicated in pubertal development [131]. 
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Materials and Methods 
 All animal-related procedures used in this study were approved by the 
Institutional Agricultural Animal Care and Use Committee (IAACUC) of the Texas 
A&M University System.  
Animal Procedures 
 Twelve Angus-sired heifers ( ½ Angus, ¼ Hereford, ¼ Brahman) were weaned at 
approximately 3 mo of age, stratified by date of birth, and assigned randomly to one of 
two dietary treatments (n = 6/treatment) in two replicates (n=6/replicate): 1) HF/LG 
[High-Forage/Low-Gain; average daily gain (ADG) of 0.45 kg/d]; 2) HC/HG [High–
Concentrate/High-Gain; ADG of 0.91 kg/d].  Diets were balanced using the Large 
Ruminant Nutrition System for cattle [164].  Targeted ADG was attained by adjustments 
in dry matter intake (DMI) based on body weight changes determined weekly.  
Ingredients and diet chemical compositions are presented in Table 1.   
 Heifers were allocated to pens measuring 25.9 x 9.5 m2 and fed an acclimation 
diet for 2 wk post-weaning.  During the first week of the adaptation period, heifers in 
both treatments were fed the HF diet up to a maximum of 2.7 kg/head daily on a pen 
basis.  During the second week of the adaptation period, heifers assigned to the HC/HG 
group were fed a diet consisting of 50% HF diet and 50% HC diet up to a maximum of 
2.7 kg/head daily on a pen basis.  Heifers assigned to the HF/LG treatment were fed the 
HF diet through the second week of the adaptation period.  Following the 2-wk 
adaptation period, heifers were fed 100% of their respective treatment diets for 13 wk.  
Heifers were weighed once a week for the duration of the experiment.   
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Table 1.   Ingredients and chemical composition of high-forage (HF) and high-
concentrate (HC) diets fed to heifers during the study. 
 
Ingredients HF  HC 
    Cracked corn, % DM 39.03  50.75 
    Soybean meal, % DM --  17.61 
    Chopped coastal Bermuda grass hay,  % DM 3.47  26.95 
    Dehydrated alfalfa meal pellet, % DM 57.30  3.83 
    Calcium carbonate, % DM --  0.86 
    Calcium monophosphate, % DM  0.20  -- 
    Vitamin A/D/E premix, mg/kg of DM 71  73 
Chemical composition     
    Metabolizable energy, Mcal/kg  2.32  2.57 
    Crude protein, % DM  14.3  17.5 
    Digestible intake protein, % CP 66%        67% 
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 At the completion of the experimental feeding period, heifers were humanely 
slaughtered after overnight fasting.  A block of tissue containing the septum, preoptic 
area, and hypothalamus was dissected and frozen in liquid nitrogen vapor.  Tissue blocks 
were stored at -80o C until further processing.  A rumen fluid sample from each heifer 
was collected immediately post-mortem and frozen at -20o C for determination of 
volatile fatty acid profile.  A single blood sample was collected and liver weights were 
obtained at slaughter.  Blood samples were placed on ice immediately after collection.  
Serum was obtained from blood samples by centrifugation and stored at -20o C. 
Hormone Assays 
 Circulating concentrations of insulin, IGF-I and leptin were determined in serum 
samples collected at the time of slaughter.  Concentrations of insulin were determined by 
a single phase RIA kit (Coat-A-Count; Siemens, Los Angeles, CA) reported previously 
for bovine serum [165, 166].  However, we used a bovine insulin preparation for 
standards (0.1, 0.2, 0.4, 0.6, 0.8, 1.0, 1.5, 2.0, and 2.5 ng/ml) and references instead of 
the human insulin standards provided with the kit.  Minimum detectable concentrations 
were 0.1 ng/ml and intra- and inter-assay coefficients of variation (CV) were 9.8 and 
14.5%.  Circulating concentrations of IGF-1 were determined in triplicate samples as 
reported previously [167], except that, for determinations reported herein, we used a 
rabbit anti-IGF-1 serum provided by the National Hormone and Pituitary Program 
(NHPP, Torrance, CA).  Concentrations of IGF-1 in samples collected at slaughter were 
determined in a single assay and intra-assay CV was 19%.  Circulating concentrations of 
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leptin were determined in a single RIA as described previously [168].  Sensitivity of the 
assays was 0.1 ng/ml and intra-assay CV averaged 13.3%. 
VFA Analysis in Ruminal Fluid 
 Ruminal fluid collected from experimental animals at slaughter was mixed 
briefly, transferred to 15-ml conical tubes, centrifuged, and the aqueous portion was 
transferred to a fresh 15-ml conical tube.  Samples were stored at -20o C until analysis 
for fatty acid composition using gas liquid chromatography [169].   
Tissue Processing 
 Frozen blocks of hypothalamic tissue were cut in coronal sections at a thickness 
of 20 µm using a cryostat.  Tissue sections were thaw-mounted on Superfrost/Plus glass 
microscope slides (Fisher Scientific, Waltham, MA; Cat #12-550-15) and frozen 
immediately.  Slides were then stored at -80o C until processing. 
RNA Isolation and Extraction 
 A single series of tissue sections 200 µm apart from each heifer was processed 
for Cresyl violet staining and observed using bright- and dark-field microscopy to 
determine the location of the ARC.  Location of the ARC was based on identification of 
well established anatomical markers [170].  A separate series of sections containing the  
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ARC was used for tissue dissection and RNA isolation.  Using a 25 G needle, an area of 
approximately 1 mm in diameter targeting the ARC was scraped from the slides (Fig 1).  
Scraped tissue was immediately placed in lysis solution (RNAqueous-Micro; Ambion, 
Austin, TX).  Scrapes were repeated in 21-54 sections and all sections were maintained 
frozen during scraping.  Total RNA was collected from tissue scrapes using 
RNAqueous-Micro (Ambion, Austin, TX) according to manufacturer instructions for the 
Laser-Capture Micro-Dissected (LCM) tissue protocol, except that RNA was harvested 
into 400 µl of Lysis Solution (RNAqueous-Micro), and precipitated with 200 µl of 100% 
ethanol.  Samples were incubated in Elution Solution (RNAqueous-Micro®) for 5 min 
before eluted through the column.  Total RNA isolated was treated with DNase to 
remove genomic DNA.  Quantity of RNA was determined using the NanoDrop ND-
1000 spectrophotometer (ThermoFisher Scientific, Wilmington, DE).  Quality of RNA 
was determined using the RNA 6000 Pico Kit (Agilent Technologies, Santa Clara, CA), 
according to manufacturer instructions. 
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FIG. 1. Cresyl violet-stained section through the mediobasal hypothalamus illustrating 
area (within dashed line) of ARC tissue dissected and removed for RNA extraction.  
Dissection was based on anatomical landmarks: VHM, ventromedial hypothalamus; 
ARC, arcuate nucleus; fx, fornix; me, median eminence; pt, pars tuberalis.  
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Microarray Procedure and Analysis 
 cRNA labeling.  Total RNA (120 ng) from each heifer was initially reverse 
transcribed to cDNA using the two-color Quick Amp Labeling Kit (Agilent).  Labeled 
cRNA was synthesized by in vitro transcription of cDNA in presence of either cyanine-3 
(Cy3) or cynanine-5 (RNA Spike-In Kit, Two-Color; Agilent) as per manufacturer’s 
instructions.  One-half of the samples from each dietary group were labeled with Cy3 
and the other half with Cy5.  Labeled cRNA was purified using RNeasy Mini columns 
(Qiagen, Valencia, CA).  Yield and specificity of cRNA were determined based on 
fluorospectrometry (NanoDrop ND-1000, Thermo Fisher Scientific).   
 Microarray hybridization.  Microarray hybridizations were conducted using the 
Agilent two-dye 4 x 44 K bovine gene expression array (Agilent Technologies, Santa 
Clara, CA).  Each array contained 44,407 valid oligo probes, 1264 of which were 
positive control probes, and 153 were negative control probes.  Each probe was 
replicated twice on each array; therefore, each array contained 21,495 unique oligos.  
 Hybridizations were performed using the Gene Expression Hybridization Kit 
(Agilent) following manufacturer instructions.  Labeled cRNA samples from one heifer 
in each of the two dietary groups were hybridized to an array, resulting in total of 6 
arrays.  The dye swap design resulted in each array being hybridized to either Cy3-
labeled HC/HG cRNA and Cy5-labeled HF/LG samples, or Cy5-labeled HC/HG and 
Cy3-labeled HF/LG samples.  Arrays were incubated at 65oC with rotation for 17 h in a 
microarray hybridization chamber.  Following hybridization, arrays were washed 
according to the Agilent Two-Color Microarray protocol (Agilent).  
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 Microarray imaging, data acquisition, normalization and analysis.  Agilent 
arrays were scanned at 5-µm resolution on an Axon GenePix 4100 scanner (Molecular 
Devices Corporation, Sunnyvale, CA).  Signal intensities were quantified using the 
GenePix pro 6.0 software (Molecular Devices Corporation, Downingtown, PA) and 
following procedures described previously [171].  Normalization of log-ratios was 
accomplished via intensity-dependent nonlinear location shift using Loess regression.  
Differential expression was assessed by fitting a linear model for each probe as follows: 
     
    Yij = Di + (-1)^cj Ai + εij  
 
 Where Yij is the observed log-ratio for probe i on array j; Di is the dye effect for 
probe i; Ai is the log-ratio between HF/LG over HC/HG for probe i, cj = 0 for j = 1,…,3 
and cj = 1 for j = 4,…,6; and the εij are assumed to be zero-mean Gaussian residual of 
constant variance.  For each probe, differential expression was detected by testing for a 
nonzero coefficient Ai in the model, which is accomplished via a Bayesian test where the 
P-value is moderated by borrowing information from correlated probes, thereby 
increasing statistical power [172].  Power is also increased by taking into consideration 
in the analysis the estimated correlation between pairs of duplicated spots.  The analysis 
is weighted such that any suspect probes (with negative quality flags) have zero weight, 
and the good probes (with zero quality flags) have weight 1.  The multiple testing 
problem is addressed by adjusting the P-values according to the False-Discovery Rate 
(FDR) [173].  
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Quantitative RT-PCR 
 Three genes exhibiting differential expression in the micro array experiment 
were selected for quantitative real-time RT-PCR analysis.  Glyceraldehyde-3-phosphate   
dehydrogenase (GAPDH) and ribosomal protein L19 (RPL19) were used as reference 
control genes.  Primers used for real-time RT-PCR were designed using Oligo 6 
software (Molecular Biology Insights, Inc., Cascade, CO) and sequences are shown in 
Table 2.  Total RNA (20 to 200 ng) isolated from the ARC was reserve transcribed to 
cDNA using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, 
Foster City, CA) and oligo (dT)20 primer (Integrated DNA Technologies, Coralville, IA).  
Briefly, PCR reactions contained 2 µl cDNA (diluted 1:4 in 25 ng/µl yeast tRNA), 10 µl 
SYBR® GreenER™ PCR master mix (Invitrogen, Carlsbad, CA), 0.6 µl of each forward 
and reverse primers and RNA-free water to a final volume of 20 µl.  Quantitative real-
time PCR was carried out in 96-well plates using the ABI Prism 7900HT sequence 
detection system (Applied Biosystems, Foster City, CA).  Cycling conditions were 95o C  
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for 10 minutes followed by 40 cycles of 95o C for 15 seconds and 60o C for 1 minute.  
Analysis of qRT-PCR 
  Quantitative RT-PCR data were analyzed using the 2-ΔΔCT method [174].   
Threshold cycle (CT) data for each gene was normalized for the mean CT values of the 
control genes GAPDH and RPL19 for each sample (ΔCT), and transformed to the 
average expression of HF/LG samples (ΔΔCT).  Mean fold change in HC/HG group was 
compared to HF/LG group. 
Statistical Analysis 
 Final body weight, overall ADG, liver weight, ruminal propionate to acetate 
ratio, hormone concentrations at slaughter, and mean fold change of selected 
differentially expressed genes were analyzed by ANOVA using the PROC MIXED 
procedure of SAS (Statistical Analysis System, Cary, NC).  For all data, the model 
included dietary treatment, replicate, and treatment by replicate interaction. 
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Table 2.   Gene name, symbol, primer sequence, and accession number for all genes 
used for qRT-PCR. 
 
Gene name 
 
Gene 
symbol 
 
Sequence of primers  
 
 
Accession No. 
Agouti-related 
protein 
AGRP GAAGAGGATAACGAACAG 
CAGGGGTTCGTGGTGGGTA 
NM_173983  
Growth 
hormone 
receptor 
GHR ATCACCACAGAAAGCCTTACCACTA 
GACAGGTATCTCAGAACTTGGAAC 
NM_176608  
Neuropeptide Y NPY AAGCAGAGATACGGGAAACGA 
ATTGGGAGGACTGGCAGACT 
NM_001014845  
Glyceraldehyde-
3-    phosphate   
dehydrogenase 
GAPDH CAGCGACACTCACTCTTCTACCTT 
GAACTCTTCCTCTCGTGCTCCT 
NM_001034034  
Ribosomal 
protein L19 
RPL19 ACCCCAATGAGACCAATGAA 
GCAGTACCCTTTCGCTTACCTAT 
NC_007317  
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Results 
Body Weight, ADG, and Ruminal VFA   
 Mean body weight at the beginning of the study did not differ (P = 0.9) between 
groups (HF/LG, 139.7 ± 6.4 kg; HC/HG, 127 kg ± 6.4 kg).  Body weight increased 
linearly in both dietary groups, with greater ADG (P < 0.0001) in HC/HG heifers (0.98 ± 
0.05 kg/d) than in HF/LG heifers (0.51 ± 0.06 kg/d) (Fig. 2).   
 Mean body weight, mean liver weight as a percentage of body weight, and 
ruminal fluid propionate:acetate ratio were greater (P < 0.02) in HC/HG heifers than in 
HF/LG heifers (Table 3).  Mean circulating concentrations of insulin and IGF-1 were 
greater (P < 0.05) at the time of slaughter in HC/HG heifers than in HF/LG heifers, and 
circulating concentrations of leptin tended to be greater (P = 0.1) in HC/HG heifers 
(Table 3).   
Microarray Gene Expression 
 After correction for FDR [173], a total of 346 genes exhibited a significant log-
ratio between HF/LG and HC/HG treatment groups (P < 0.05). Among the 346 
differentially expressed genes, 229 exhibited increased and 117 exhibited decreased  
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FIG. 2.   Mean (± SEM) body weights of heifers weaned at 3 mo of age and fed either a 
high-forage/low-gain (HF/LG) or a high-concentrate/high-gain diet (HC/HG) for 13 wk.  
Body weight of HC/HG heifers was greater than HF/LG heifers beginning at week 10 (P 
< 0.06) and continuing through week 13 (P < 0.03).  
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Table 3.   Mean (± SEM) body weight, liver weight, rumen propionate:acetate ratio, and 
serum concentrations of metabolic hormones at time of slaughter in heifers fed high-
forage/low-gain (HF/LG) or high-concentrate/high-gain (HC/HG) diets for 14 wk 
beginning at 16 ± 1 wk of age.                                                                            
Variable HF/LG HC/HG 
 
P-value 
Body weight, Kg 172.12 ± 9.19 218.49 ± 11.47 0.02 
  Liver weight, % of BW 1.07 ± 0.04 1.42 ± 0.04 0.003 
  Propionate:acetate  0.23 ± 0.01 0.31 ± 0.01 0.001 
  Insulin, ng/ml 0.94 ± 0.17 1.16 ± 0.26 0.05 
  IGF-1, ng/ml 52.01 ± 4.39 103.75 ± 9.9 0.002 
Leptin, ng/ml 2.55 ± 0.35 3.62 ± 0.43 0.1 
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Table 4. Gene symbol, gene description and fold change of 10 genes exhibiting greater 
expression (P < 0.05) in heifers fed high-concentrate diets to gain body weight at a high-
rate (0.91 kg/d) than heifers fed high-forage diets to gain body weight at a low rate (0.45 
kg/d). 
 
Gene Description 
 
Gene Symbol 
 
Fold Change 
Transmembrane protein 149 TMEM149 3.06 
General transcription factor 
IIH, polypeptide 5  
GTF2H5 2.04 
G protein-coupled receptor 45 GPR45 2.01 
Agouti protein  AGOUTI 1.82 
Similar to SEC14p-like protein 
TAP3, transcript variant 1  
LOC513294 1.76 
Similar to dedicator of 
cytokinesis 6  
LOC539711 1.64 
Dentin sialophosphoprotein DSPP 1.58 
Tensin 4 TNS4 1.48 
Toll-like receptor 6 (tlr6) TLR6 1.48 
Ras-related associated with 
diabetes  
RRAD 1.42 
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Table 5. Gene symbol, gene description and fold change of 10 genes exhibiting greater 
expression (P < 0.05) in heifers fed high-forage diets to gain body weight at a low rate 
(0.45 kg/d) than in heifers fed high-concentrate diets to gain body weight at a high-rate 
(0.91 kg/d).   
 
Gene Description 
 
Gene Symbol 
 
Fold Change 
Agouti related protein AGRP 4.72 
Alpha-1 acid glycoprotein ORM1 4.18 
Neuropeptide Y NPY 3.3 
Similar to KIAA0748 gene 
product, transcript variant 1 
LOC538993 1.84 
Similar to CRYM transcript 
variant 1 
CRYM 1.8 
Similar to collagen, type IX, 
alpha 3 
LOC504788 
 
1.76 
Corticotropin releasing 
hormone 
CRH 1.42 
Similar to glutamate receptor 
interacting protein 1 
LOC519502 
 
1.38 
Retinol binding protein-1 RBP1 1.14 
Regulator of G-protein 
signaling 2, 24kDa 
RGS2 1.4 
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expression in HC/HG heifers compared to HF/LG heifers.  The top 10 genes exhibiting 
greater expression in HC/HG heifers compared to HF/LG heifers are represented in 
Table 4, and the top 10 genes exhibiting greater expression in HF/LG heifers compared 
to HC/HG heifers is represented in Table 5. 
qRT-PCR of Selected Genes 
 NPY, AGRP and GHR genes were selected as specific genes of interest out of the 
346 differentially-expressed genes. These genes are specifically involved in signaling 
metabolic status to the reproductive neuroendocrine axis.   Quantitative RT-PCR 
analysis of these genes confirmed microarray observations and indicated that mean 
expression of NPY, AgRP and GHR was lower (P < 0.02) in HC/HG heifers than in 
HF/LG heifers (Fig. 3). 
Discussion 
 The ARC is a major area of the hypothalamus that integrates complex signaling 
pathways that regulate metabolic and reproductive functions.  Since the initiation of 
puberty is greatly influenced by nutritional balance and metabolic status, we sought to 
examine an array of genes within the ARC that may be responsive to, and/or mediate the 
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FIG. 3.   Normalized mean (± SEM) expression of neuropeptide-Y (NPY), agouti-related 
protein (AGRP), and growth hormone receptor (GHR) genes in the arcuate nucleus of 
heifers fed a high-forage diet to gain body weight at a low rate (HF/LG) and heifers fed a 
high-concentrate diet to gain body weight at a high rate (HC/HG).  Expression is relative 
to mean normalized expression of HF/LG samples in the experiment.  
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effects of, nutritional inputs known to affect the process of sexual maturation.  The 
precocious puberty model in heifers described by Gasser et al [8, 13-15] provides an 
ideal approach for examining the involvement of the ARC in the nutritional regulation of 
neuroendocrine function during the early juvenile development.  The current studies 
provided evidence that a considerable number of genes expressed within the ARC are 
regulated by nutrient intake concurrent with the development of distinct metabolic and 
hormonal states. 
 Using microarray gene expression analysis, we identified a total of 346 genes 
that were differentially expressed between HC/HG and HF/LG heifers at the end of the 
13-wk feeding period (7 mo of age).  This observation demonstrated that the heifer is 
exquisitely sensitive to nutritional input during early calf-hood.  Importantly, nutrient 
requirements for maintenance were met, and both groups of heifers were in positive 
energy balance.  However, source and amount of nutrients available for growth differed 
between treatment groups.  Therefore, differences in gene expression within the ARC 
between heifers growing at distinct rates indicate that the state of nutrient sufficiency to 
support growth involves functional changes within the hypothalamus early in 
development.  We propose that those changes may be important for early maturation of 
the reproductive neuroendocrine axis.  In mice, neuronal projections originating in the 
ARC toward hypothalamic regions that regulate metabolism and feed intake are 
established during the first two weeks after birth [175].  This observation suggests that 
the early juvenile period of development is critical for development of hypothalamic 
pathways that control neuroendocrine functions during maturation and adulthood.   
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Of the differentially-expressed genes identified in the microarray study, 
expression of NPY, AGRP, and GHR genes were confirmed by qRT-PCR. Neuropeptide 
Y and AGRP are known to be intimately involved in signaling metabolic status to the 
central reproductive axis through neuronal pathways emanating from within the ARC 
[90, 91, 124, 125].  Neuropeptide Y projections are observed in close proximity to 
GnRH neurons and dendrites in the POA [6] and GnRH fibers in the ME [5]. 
Neuropeptide Y5 receptor has been localized in GnRH neurons [5, 6], indicating direct 
actions of NPY upon GnRH neurons.  Furthermore, NPY expression increases during 
negative energy balance and decreases during adequate or excess energy. Therefore, 
because of its involvement in the control of reproductive function in sexually-mature 
animals [91, 105, 115, 116], NPY is a major focal point in our efforts to understand 
mechanisms associated with the metabolic control of sexual maturation.  Importantly, 
treatment of female rats with NPY delays sexual maturation and disrupts reproductive 
cyclicity [105].  Furthermore, McShane and co-workers have reported that icv 
administration of NPY to estradiol-implanted, ovariectomized ewes reduced release of 
LH [108]. Others have reported that NPY administration suppresses circulating 
concentrations of LH by inhibiting pulsatile release of GnRH and LH in ovariectomized, 
estradiol-implanted cattle [115, 116].  Additionally, acute central treatment of NPY 
inhibits secretion of LH in mature, ovariectomized cattle pretreated with leptin [175], 
suggesting that NPY signaling may be downstream of leptin’s actions.  Based on 
previous reports [8, 13-15], the nutritional strategies employed in the current experiment 
were designed to promote a relatively high rate of body weight gain, which when 
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associated with high concentrate diets have been shown to markedly hasten puberty in 
heifers.  Thus, our observation of decreased NPY expression in the ARC of HC/HG 
heifers compared to HF/LG support the hypothesis that NPY neuronal pathways may 
serve as metabolic integrators of pubertal process.  Specifically, elevated NPY 
expression in the ARC may serve as a metabolic ‘brake’ for pubertal onset.  However, 
the neuroendocrine mechanisms and pathways by which NPY exerts this function 
remain unclear, but may involve differential NPY projections that are established during 
early calf-hood development.  Alterations in hypothalamic neuronal circuitry associated 
with nutritional inputs have been observed in during early postnatal development in 
rodents [177]. 
 The majority of the NPY neurons in the ARC co-express AGRP [47] which 
function together to increase energy balance in times of inadequate nutrition.  In the 
current study, differential expression of AGRP between HC/HG and HF/LG heifers were 
parallel to that of NPY.  Agouti-related peptide is an antagonist of melanocortin 
receptors (MCR) and blocks the actions of α-melanocortin stimulating hormone (α-
MSH) [119].  Hypothalamic α-MSH is cleaved from its polypeptide precursor, POMC, 
during post-translational processing and upon binding to MCR suppresses appetite and 
feeding behavior.  It has been suggested previously that AGRP exerts negative 
modulatory effects on GnRH neurons [124, 125] and thus ultimately, secretion of 
gonadotropins from the adenohypophysis.  The MC4R is expressed in the ARC, PVN, 
and medial POA [127]. Moreover, it is expressed in immortalized hypothalamic GnRH-
secreting GT-1 cells [128], but it is unclear if they are expressed specifically on GnRH 
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neurons.  Based on in vitro experiments, AGRP does not appear to affect gonadotropin 
secretion directly in cultured pituitary cells [126].  The apparent role of AGRP is to 
function in synchrony with NPY to increase appetite and feeding behaviors by blocking 
the actions of α-MSH.  Similarly to NPY, AGRP expression was more abundantly 
expressed in HF/LG than in HC/HG heifers.  Thus, AGRP may bolster NPY’s actions as 
a metabolic ‘brake’ on pubertal onset by suppressing GnRH release.  Previously, it has 
been demonstrated that nutritional inputs during early postnatal development affect 
neuronal development of AGRP projections in the hypothalamus [177]. 
  The current study also revealed that GHR expression was decreased in HC/HG 
heifers relative to HF/LG.  Growth hormone is the cognate ligand for GHR and GH 
secretion is regulated by an intricate interaction between growth hormone-releasing 
hormone (GHRH) and somatostatin actions in somatotrophs [178].  Growth hormone-
releasing hormone neurons in the ARC express few GHR [179], however, the majority 
(95%) of NPY neurons in the ARC express GHR [180].  In addition, evidence indicates 
that NPY neurons act as an intermediate step in the regulation of GH [180].  In rats, 
hypophysectomy caused a significant reduction of NPY mRNA expression in the ARC, 
and treatment with GH restored mRNA levels to that of control animals [180].  This 
indicates a direct regulation of NPY expression by GH, likely via GHR on NPY neurons 
in the ARC.  Concentrations of GH in circulation tend to decrease during juvenile 
growth and are low at puberty, particularly in heifers gaining weight at high rates [180].  
Therefore, it is possible that the elevated nutritional status promoted in the HG/HG 
group supports alterations in the NPY system involving GH signaling.  Nevertheless, 
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previous reports from our laboratory [115] and from others [182, 183] have 
demonstrated paradoxical but clear stimulatory effects of NPY on the release of GH in 
cattle and sheep. Thus, the interrelationships between NPY and GH release remain 
ambiguous, but seem to reinforce a metabolic status that may be permissive (if 
suppressed) or restrictive (if maintained elevated) to reproductive maturation. 
 The greater circulating concentrations of leptin and insulin in HC/HG compared 
to HF/LG heifers confirm the elevated nutritional status in that group, and the greater 
concentrations of IGF-1 in circulation support greater potential for increased somatic 
growth.  The increase in mean circulating concentrations of leptin in HC/HG heifers is 
congruent with the observed decrease in expression of NPY and AGRP, because leptin 
has been shown to suppress NPY and AGRP gene expression and release [71, 79, 123].  
Leptin also positively modulates GH secretion under fasting conditions by direct actions 
at the anterior pituitary [184] and attenuates the stimulatory effects of NPY on GH 
release in cattle [176].  In addition, numerous studies have demonstrated the close 
association between secretion patterns of leptin and insulin.  Similar to leptin, insulin 
also has negative regulatory effects on NPY and AGRP expression. 
The foregoing changes in metabolic hormones and in expression of key 
regulatory genes in the ARC are also congruent with the observed changes at slaughter 
of ruminal volatile fatty acid content. In ruminants, propionate is readily converted to 
glucose in the liver, whereas acetate is not [11].  Elevated hepatic function may explain 
increased liver weight in HC/HG heifers, supporting increased hepatic IGF-1 synthesis 
and maintaining greater concentrations of IGF-1 in circulation.    
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 In summary, our results have confirmed marked differences in gene expression 
within the ARC in heifers nutritionally programmed to hasten or delay pubertal onset.  
Among the differently-expressed genes, NPY, AGRP, and GHR exhibited decreased 
expression under nutritional conditions that promoted a relatively high rate of gain.  
These genes are known to be involved in the neuroendocrine control of metabolic 
functions, and interact to regulate the reproductive neuroendocrine axis. Therefore, it is 
possible that nutritionally-induced changes in expression of these genes during juvenile 
development may also serve as key signals for regulating puberty. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
56	  
	  
CHAPTER IV 
 
EFFECTS OF TWO LEVELS OF DIETARY CONCENTRATE AND BODY 
WEIGHT GAIN DURING THE JUVENILE PERIOD ON METABOLIC 
ENDOCRINE STATUS AND AGE AT PUBERTY IN HEIFERS 
 
Introduction 
 Reproduction is an energy-demanding physiological process that is greatly 
influenced by nutrition. Thus, appropriate nutritional balance is a prerequisite for 
juvenile animals to proceed through pubertal development and to insure continuing 
reproductive capacity in adulthood.  Puberty is the result of progressive developmental 
changes within the brain that lead to the attainment of reproductive capacity.  In 
maturing heifers, it is important to attain reproductive capacity well in advance of the 
beginning of the first breeding season to increase the probability of conception early in 
that breeding season and to maximize lifetime productivity [2-4].   
 One currently accepted viewpoint is that a critical window exists during early 
calf-hood development in heifers in which sensitivity to dietary quality and quantity is 
heightened [8, 13-16].  Consequently, dietary manipulations during this period can have 
a profound influence on the timing of puberty.  Specifically, heifers weaned at 3 mo of 
age and fed diets high in starch that promote high rates of body weight gain between 3 
and 7 mo of age exhibit an increased tendency to reach puberty precociously (≤ 300 d) 
and at lower body weight than heifers fed to gain weight at a lower rate [13-15].  In 
ruminants, diet composition and quantity are critical determinants of the type and 
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amount of volatile fatty acids (VFA) produced during fermentation [11, 184].  Although 
acetate is produced in larger quantities in the rumen, it does not exhibit the 
gluconeogenic properties of propionate; thus in ruminants, propionate is the primary 
substrate utilized in gluconeogenesis [11, 12].  Increasing dietary starch in the diet 
promotes ruminal propionate production and increases propionate to acetate ratio.  
Therefore, greater amounts of highly-soluble carbohydrates in the diet provide greater 
energy substrates to the animal for immediate use, as well as for accumulation of body 
fat mass during growth and development.  However, it is unclear if the cues driving 
precocious puberty in heifers fed high-starch diets are created as a result of the 
gluconeogenic nature of the diet, or if the same effect can be created with a high-forage, 
acetate- favoring diet that promotes a similar rate of body weight gain.  In the studies 
reported herein, early-weaned heifers were utilized to investigate the interaction of 
dietary energy source (propionate or acetate-favoring diets) and rate of body weight gain 
on long-term secretion patterns of metabolic signaling hormones and age at puberty.   
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Materials and Methods 
 All animal-related procedures in this study were approved by the Institutional 
Agricultural Animal Care and Use Committee (IAACUC) of the Texas A&M University 
System.  This experiment was conducted at the Texas AgriLife Research station, 
Beeville, TX.   
Animals and Experimental Design  
 Forty-eight Angus-sired heifers out of Brahman x Hereford F1 dams from the 
Texas AgriLife Research-Beeville herd were weaned at 14 ± 1 wk of age and stratified 
by date of birth.  Heifers were allocated randomly within stratification into 1 of 4 
treatment groups in a 2 x 2 factorial arrangement (2 diets and 2 rates of body weight 
gain) involving 2 replicates and 6 heifers/group. Treatment groups were: 1) High-
Forage, Low-Gain (HF/LG; 0.45 kg/d); 2) High-Forage, High-Gain (HF/HG; 0.91 kg/d); 
3) High-Concentrate, Low-Gain (HC/LG; 0.45 kg/d); 4) High-Concentrate, High-Gain 
(HC/HG; 0.91 kg/d).  Diets were balanced using the Large Ruminant Nutrition System 
for cattle [164].  Heifers were fed their respective diets once daily in the morning.   
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Ingredients and chemical composition for the high-forage and high-concentrate diets are 
represented in Table 6.  Targeted ADG was attained by adjusting to dry matter intake 
(DMI) based on ADG.  
 Heifers in each dietary treatment were placed in pens measuring 25.9 x 9.5 m and 
fed an acclimation diet for 2-wk post-weaning.  During the first week of the acclimation 
period, heifers in HC and HF groups were offered the HF diet up to a maximum of 2.7 
kg/head daily on a pen basis.  During the second week of the adaptation period, heifers 
assigned to HC treatment groups were offered a diet consisting of 50% HF and 50% HC 
up to a maximum of 2.7kg/head daily on a pen basis.  After the 2-wk adaptation period, 
heifers were fed 100% of their respective diets (HC or HF) for the following 14 wk.  
After the 14 wk dietary treatments, all heifers were switched to a common diet that 
included a corn-cottonseed meal-based supplement designed to promote a moderate 
(0.68 kg/d) rate of body weight gain, and free choice Coastal Bermuda grass hay, until 
puberty was confirmed. 
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Table 6.   Ingredients and chemical composition of high-forage (HF) and high-
concentrate (HC) diets fed to heifers during the 14-wk dietary treatment period.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Ingredients  HF  HC 
    Cracked corn, % DM 39.03  50.75 
    Soybean meal, % DM --  17.61 
    Chopped coastal Bermuda grass hay, % DM  3.47  26.95 
    Dehydrated alfalfa meal pellet, % DM 57.30  3.83 
    Calcium carbonate, % DM --  0.86 
    Calcium monophosphate, % DM 0.20  -- 
    Vitamin A/D/E premix, mg/kg of DM 71  73 
Chemical composition    
    Metabolizable energy, Mcal/kg of DM 2.32  2.81 
    Crude protein, % DM 13.8  17.8 
    Digestible intake protein, % CP 61  69 
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Blood Collection and Determination of Puberty 
 Blood collection during the experiment was performed prior to feeding by caudal 
venipuncture and samples were placed immediately on ice.  Blood samples were 
collected once a week during the dietary treatment period and common growth period 
until heifers reached approximately 35 wk of age, after which blood was collected twice 
weekly until puberty was confirmed.  Plasma or serum was harvested and stored at -20oC 
until analyses for circulating concentrations of hormones.  Puberty was confirmed by 
observing serum concentrations of progesterone ≥ 2 ng/ml in at least two consecutive 
samples.  Once puberty was confirmed, heifers were removed from the study.   
Hormone Assays 
 Circulating concentrations of leptin, insulin, IGF-1, and glucose were determined 
in plasma samples collected during weeks 0, 2, 4, 6, 8, 10, 12 and 14 of the dietary 
treatments.  Circulating concentrations of leptin, insulin, and IGF-1 from the common 
growth period were determined in serum samples in the 5 periods preceding puberty, and 
at puberty.  “Period” consisted of samples collected every third week during the 
common growth period.  Differences in age at puberty allowed only for analysis of the 5 
periods preceding puberty without significantly decreasing sample size.  Circulating 
concentrations of leptin were determined in a single RIA as described previously [168].  
Minimum detectable concentration was 0.1 ng/ml with intra- and inter-assay CV of 1.8 
and 3.8%.  Concentrations of insulin were determined using a solid-phase 125I-RIA Coat-
A-Count kit developed for human serum (Siemens, Los Angeles, CA) and reported 
previously for bovine serum samples [165, 166].  However, we used a bovine insulin 
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preparation for standards (0.1, 0.2, 0.4, 0.6, 0.8, 1.0, 1.5, 2.0, and 2.5 ng/ml) and 
references instead of the human insulin standards provided with the kit.  Minimum 
detectable concentrations were 0.1 ng/ml with intra- and inter-assay CV of 9.2 and 
23.6%, respectively.  Circulating concentrations of IGF-1 were determined in triplicate 
samples as reported previously [167], except that, for determinations reported herein, we 
used a rabbit anti-IGF-1 serum provided by the National Hormone and Pituitary Program 
(NHPP, Torrance, CA).    Minimum detectable concentrations were 0.3 ng/ml and intra- 
and inter-assay CV were 7.4 and 19.1%, respectively.  Concentrations of glucose were 
quantified using an enzymatic kit assay (Wako Diagnostics, Richmond, VA).   
Statistical Analysis 
 Effects of diet, rate of body weight gain, wk (14-wk dietary treatment period), 
period (common growth period), replicate, and all possible interactions on BW and 
hormone concentrations were analyzed by analysis of variance (ANOVA) using the 
MIXED procedure of SAS (SAS Inst. Inc., Cary, NC).  The repeated measures model 
was:  
Yijklm = µ + Dj + Gk + hi:j:k + Tl + Rm + (DG)jk + (DT)jl + (GT)kl + (DR)jm + (GR)km + 
(DGT)jkl + (DGR)jkm + eijk 
 Yijklm is the observation of the i th heifer in the j th diet and k th gain group during 
the l th week/period in the m th replicate, µ = the overall mean, Dj = j th diet, Gk = k th 
gain, Tl = l th week/period, Rm = m th replicate, hi:j:k = random effect of the i th heifer 
within the j th diet and k th gain group, (DG)jk = diet x gain interaction, (DT)il = diet x 
time interaction, (GT)kl = gain x time interaction, (DR)jm = diet x replicate interaction, 
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(GR)km = gain x replicate interaction, (GDT)jkl = diet x gain x time interaction, (GDR)jkm = 
gain x diet x replicate interaction, an eijk = random residual effect.   
 Since circulating concentrations of insulin, IGF-1 and glucose differed (P < 0.05) 
among treatment groups at week 0, analysis of covariance using values at wk 0 as 
covariates was employed.   
 The effects of diet, ADG, and replicate on body weight at puberty and age at 
puberty were analyzed by ANOVA for a single observation using the MIXED procedure 
of SAS (Cary, NC) (model: Yjkm = µ + Dj +  Gk + (Dj x Gk) + Rm + ejk, with notation as 
defined previously).   
 If replicate (Rm) was not significant (P > 0.05), it was excluded from the model 
and all heifers were treated as one replicate.  Least squares means were compared using 
the PDIFF command incorporating the Tukey Honest Significant Difference (HSD) test 
for multiple comparisons.  Statistical significance was accepted at P < 0.05. 
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 Results  
             One heifer from the HC/LG dietary treatment group was removed during the 14-
wk dietary treatment period due to lack of normal growth.  A second heifer from the 
HC/LG dietary treatment group was removed from all analyses due to significant over 
performance.  Thus, all analyses for the HC/LG dietary treatment group were conducted 
with only 10 heifers.   
Body Weight, ADG, and Age at Puberty 
 Mean body weight at the beginning of the study did not differ between groups 
and averaged 140.22 ± 2.62 kg (Fig. 4).  Although body weight increased linearly in all 
dietary groups, ADG was greater (P < 0.04) in HG heifers (0.81 ± 0.06 kg/d) than in LG 
heifers (0.44 ± 0.06 kg/d).  Heifers in the HG dietary groups became significantly 
heavier after 8 wk of feeding (24 ± 1 wk of age) and remained heavier throughout the 
remainder of the dietary treatment (P < 0.0001).   
 During the common growth period, heifers gained 0.66 ± 0.14 kg/d, and mean 
body weight at puberty did not differ between dietary groups (332.75 ± 7.04 kg).   Mean 
age at puberty did not differ between dietary treatment (HF or HC), however HG heifers 
reached puberty at a younger age (54.5 ± 1.8 wk) than LG heifers (60.2 ± 1.9 wk; P < 
0.04) (Table 7.).   
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FIG. 4.   Mean (± SEM) body weights of heifers weaned at 14 ± 1 wk of age and fed 
high-forage or high-concentrate diets for 14-wk to gain body-weight at a low (0.45 kg/d; 
LG) or high (0.91 kg/d; HG) rate.  After 8 wk of feeding (24 ± 1 wk of age) HG heifers 
became significantly heavier than LG heifers, and remained so during the rest of the 14-
wk dietary treatment period (*P < 0.0001) .  
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Table 7.  Average daily gain (ADG), body weight at start of trial, body weight at end of 
14-wk dietary treatment period, body weight at puberty, and age at puberty for heifers in 
all treatment groups.   
                                                 
                              Dietary Treatment 
 
 
Variable 
High-Forage 
Low-Gain 
(n=12) 
High-Concentrate 
Low-Gain    
(n=10) 
High-Forage        
High-Gain                       
(n=12) 
High-Concentrate 
High-Gain    
(n=12) 
   
ADG 
 
0.44 ± 0.05a , 
kg/d 
 
0.43 ± 0.06a,       
kg/d 
 
0.74 ± 0.06b, 
kg/d 
 
0.88  ± 0.06b,      
kg/d 
   
Body weight at       
start of trial 
 
139.38 ± 5.34 
kg/d 
 
141.62 ± 5.97,     
kg/d 
 
142.57 ± 
5.34, kg/d 
 
137.45 ± 5.34,     
kg/d 
   
Body weight at 
end of 14-wk 
dietary treatment 
 
182.35 ± 
8.35c,  kg/d 
 
184.13 ± 9.33c,                  
kg/d 
 
215.35 ± 
8.35d, kg/d 
 
223.83 ± 8.35d,      
kg/d 
   
Body weight at 
puberty 
 
347.0 ± 13.5, 
kg/d 
 
330.17 ± 15.1,      
kg/d 
 
333.58 ± 
13.5, kg/d 
 
325.5 ± 13.5,         
kg/d 
 
Age at puberty       
 
60.3 ± 2.6, 
weeks 
 
59.9  ± 2.9        
weeks 
 
54.33 ± 2.6 
weeks 
 
54.75 ± 2.6,       
weeks 
Row means with different superscripts differ (a, b P < 0.004; c, d P = 0.07)  
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Circulating Metabolic Hormones 
 Heifers in the HC/HG treatment group exhibited greater concentrations of 
circulating leptin than HF/LG and HF/HG heifers (P = 0.1) after 8 wk of feeding (24 ± 1 
wk of age), and remained elevated throughout the remainder of the dietary treatment 
period (P < 0.01) (Fig. 5).   
 Although concentrations of circulating insulin did not consistently among  
treatment groups during the 14-wk dietary treatment period, circulating concentrations of 
insulin were greater in HG heifers than in LG heifers after 4 wk (20 ± 1 wk of age; P = 
0.01), 6 wk (22 ± 1 wk of age; P = 0.1) and 14 wk (30 ± 1 wk of age; P < 0.04) of 
feeding.  No effect of dietary treatment was observed (Fig. 6).  Mean concentrations of 
IGF-1 were not affected by dietary treatment or ADG during the 14 wk dietary treatment 
period.  Overall mean concentrations of glucose were greater (P < 0.006) in HG heifers 
(64.78 ± 1.74 ng/ml) than LG heifers (57.35 ± 1.85 ng/ml) during the 14-wk dietary 
treatment period, but did not differ significantly by week (FIG. 7).   
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FIG. 5.   Mean (± SEM) concentrations of circulating leptin in heifers fed high-forage 
(HF) and high-concentrate (HC) diets to gain body weight at low (LG) and high (HG) 
rates for 14 wk beginning at 16 ± 1 wk of age.  Heifers in the HC/HG treatment group 
exhibited greater concentrations of circulating leptin than HF/LG and HF/HG heifers (*P 
= 0.1) after 8 wk of feeding (24 ± 1 wk of age), and remained elevated throughout the 
remainder of the dietary treatment period (**P < 0.01). 
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FIG. 6.   Mean (± SEM) concentrations of circulating insulin in heifers fed high-forage 
and high-concentrate diets to gain body weight at low (LG) and high (HG) rates for 14 
wk beginning at 16 ± 1 wk of age.  Circulating concentrations of insulin were greater in 
HG heifers than in LG heifers after 4 wk (20 ± 1 wk of age; P = 0.01), 6 wk (22 ± 1 wk 
of age; P = 0.1) and 14 wk (30 ± 1 wk of age; P < 0.04) of feeding.   
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FIG. 7. Mean (± SEM) concentrations of circulating glucose in heifers fed high-forage 
and high-concentrate diets to gain body weight at low (LG) and high (HG) rates for 14 
wk beginning at 16 ± 1 wk of age.  Overall mean concentrations of glucose were greater 
(*P < 0.006) in HG heifers than LG heifers during the 14-wk dietary treatment period, 
but did not differ significantly by week.   
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Circulating concentrations of leptin were greater in HF heifers (P < 0.03) than in HC 
heifers at puberty (Fig. 8).  Circulating concentrations of insulin differed between diet 
and replicate during the common growth period.  High forage heifers in replicate 1 
exhibited greater concentrations of insulin than HC heifers beginning at period 5 (P < 
0.03) of the common growth period, and remained greater until puberty (P < 0.02) (Fig. 
9a).  Concentrations of insulin in replicate 2 heifers were not affected by diet, gain or 
period during the common growth period (Fig. 9b).  Mean concentrations of IGF-1 
differed by period (P < 0.0004) during the common growth period, however did not 
differ by diet or gain (Fig. 10).   
Discussion 
 Feeding diets high in energy to early-weaned beef heifers in amounts that 
promote a high rate of gain has been shown to markedly decrease age at puberty [8, 13-
15], including heifers with Bos indicus influence [81].  However, no studies have 
examined whether the source of dietary energy (concentrate or forage), and thus the type 
of ruminal volatile fatty acid production pattern, is an important factor in this process.   
In the current study, we set out to examine these relationships during a period of 
development in the heifer that is critical for early onset of puberty, and the associated 
endocrine patterns. In the current study, dietary treatment had no effect on age at  
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FIG. 8.   Mean (±SEM) circulating concentrations of leptin during the common growth 
period preceding puberty (P) in heifers fed high-forage (HF) and high-concentrate (HC) 
diets.  Concentrations of leptin in HF heifers were greater than HC heifers at puberty 
(**P < 0.03).  
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FIG. 9. Mean (± SEM) circulating concentrations of insulin during the common growth 
period preceding puberty (P) in heifers fed high-concentrate (HC) and high-forage (HF) 
diets.  In replicate 1 (a), insulin was greater in HF than HC heifers at puberty, and during 
the 4 preceding periods (*P < 0.02).  Neither diet nor period was a significant source of 
variation in replicate 2 (b) heifers.   
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FIG. 10.  Mean (± SEM) concentrations of IGF-1 in all heifers during the common 
growth period preceding puberty (P).  Mean concentrations of IGF-1 differed by period 
(a,b P < 0.0004)  however did not differ by diet or gain (Fig. 10).   
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puberty; however, heifers in both HG groups reached puberty at younger ages (54 wk) 
than heifers in the LG groups (60 wk).  Nonetheless, very few heifers exhibited 
precocious puberty (≤ 43 wk).  Several studies by Gasser and co-workers [13-15], in  
addition to previous observations in our laboratory [81], demonstrated that early weaned 
heifers fed high-concentrate diets until puberty become pubertal at earlier ages than 
heifers fed control diets.  Unlike the studies by Gasser and others [13-15] and Garcia and 
others [81], where a high incidence of precocious puberty was observed, heifers in the 
current study were not fed experimental diets continuously until puberty was confirmed.  
In the current study, heifers were weaned at approximately 3.5 mo of age and following 
a 2 wk acclimatization period, were fed experimental diets for 14 wk, after which they 
were switched to a common growth diet to stimulate a moderate average daily gain.  The 
timing and duration of the dietary treatment period is similar to an additional study by 
Gasser and others [8] in which heifers were weaned at approximately 3 months of age 
and fed high-concentrate or control diets for 70 days, after which half from each group 
were switched to the opposite diet until puberty.  A greater percentage (67%) of heifers 
fed the high-concentrate diets continuously after weaning demonstrated precocious 
puberty than those switched to the control diet (47%) and those fed a control diet and 
switched to a high-concentrate diet (47%) [8].   Although a high incidence of precocious 
puberty was not observed in the current study, it must not be overlooked that heifers 
gaining body weight more rapidly during the juvenile period reached puberty at earlier 
ages that those gaining at a slower rate.   
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 It is possible that individual genotype and phenotype is also an important 
consideration affecting age at puberty.  Bos indicus x Bos taurus crossbred cattle are 
typically later maturing (14-16 mo of age) than straight Bos taurus cattle [19] which 
usually reach puberty between 11 and 14 mo of age.  However, there is great variability 
in this phenomenon in both straight Bos taurus and Bos indicus x Bos taurus cattle.  
Although the heifers used in the current study were quite similar to those used 
previously in this laboratory, it is possible that there was a greater number of heifers 
with a later-maturing phenotype (larger frame score; heavier mature weight) compared 
to those involved in the earlier report [81].  Based on results reported in the current 
study, and results from the latter of Gasser’s studies [8], we speculate that heifers exhibit 
heightened sensitivity to dietary intake from 3-7 months of age, and that the period of 
time following 7 months of age is equally critical for accelerating pubertal development.  
Additionally, perhaps had the dietary treatment period been extended beyond 7 months 
of age, a greater number of animals would have reached precocious puberty.  Since no 
difference in age at puberty was observed between heifers fed high-concentrate and 
high-forage diets, it would appear that only rate of body weight gain is a significant 
factor in accelerating pubertal development.  Nonetheless, since neither HG group 
exhibited high rates of precocious puberty, additional work would be required in order to 
extend this conclusion to the occurrence of precocious puberty.  
 The pattern of circulating leptin in the HC/HG heifers during the 14-wk dietary 
treatment period differed markedly from all other groups.  Beginning at approximately 
24 wk of age, after 8 wk of feeding, heifers in the HC/HG group exhibited a marked 
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increase in concentrations of circulating leptin that was sustained for the remainder of 
the 14-wk post-weaning period.  Concentrations of leptin in all other treatment groups 
remained relatively unchanged during the same period.  Importantly, once heifers in the 
HG-HC treatment group were switched to the common growth diet, concentrations of 
leptin decreased to values similar to those observed in all other treatment groups.   
Leptin signaling is essential for normal reproductive function to occur [65], and although 
leptin alone has not been demonstrated to accelerate the maturation of the hypothalamic-
hypophyseal complex in heifers [70, 73], it is believed to have a permissive effect on the 
initiation of puberty.  Garcia et al. and others reported that normally-developing heifers 
exhibit a progressive increase in circulating leptin as puberty approached [69, 81].  In the 
current study, a gradual increase in serum leptin in heifers in 3 of 4 dietary treatment 
groups (HF/HG, HF/LG, HC/LG) was observed during the 14-wk dietary treatment 
period.  However, in the HC/HG group, the abrupt increase noted in serum leptin 
between 24 and 30 wk of age did not wane until heifers were switched to the common 
growth diet at the end of the 14-wk dietary treatment. This distinguishing feature of the 
HC/HG group could represent an important signal for neurons within the hypothalamus 
during a critical window of development and is likely indicative of metabolic responses 
to the combination of high-energy feeding and high-rate of gain.  In particular, perhaps 
sustained leptin signaling after 7 months of age, in addition to the 3-7 month juvenile  
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period, is necessary for acceleration of pubertal development.  Interestingly, HC heifers 
demonstrated a progressive decrease in concentrations of leptin as puberty approached, 
and HF heifers exhibited greater concentrations of leptin at puberty.   
Circulating concentrations of insulin also was affected by rate of gain during the 
14-wk dietary treatment period, although not to the same extent as leptin.  Similar to 
leptin, HF heifers exhibited greater concentrations of circulating insulin than HC heifers 
during the common growth period, although only in replicate 1.  It is of no surprise that 
leptin and insulin displayed similar patterns during the common growth period since 
both hormones tend to change in the same direction in response to dietary alterations.  
However, the elevation of both hormones in HF heifers was unexpected, particularly 
since only heifers in one replicate demonstrated a difference in serum insulin.   
 In summary, the endocrine responses observed in the current work are similar to 
those normally associated with pubertal development in heifers [25, 69, 81].  In general, 
it appears that ADG in the current experiment was the most important variable affecting 
age at puberty.  However, the pattern of leptin secretion that was unique to HC/HG 
heifers is an interesting and potentially relevant finding that may contribute to our 
understanding of hormonal cues involved in acceleration of the pubertal process. The 
dramatic increase observed for this variable in the HC/HG group suggests the possibility 
that dietary energy source does play an important role in regulating hormonal cues  
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during development.   Thus, had we extended the duration or altered the timing of the 
experimental feeding period postweaning,  we may have observed a high frequency of 
precocious puberty  similar to that observed previously [8, 13-15, 81].   In the  
experiment described in the previous chapter, we observed a marked reduction in 
expression of NPY, AgRP, and GHR genes in the ARC of heifers fed the HC/HG diet 
compared to HF/LG. Those changes are consistent with a reduction in inhibitory tone 
within the reproductive neuroendocrine system. Thus, although heifers in that 
experiment were slaughtered well before puberty, observations from two studies, 
including differential gene expression in the ARC (Experiment 1) and abrupt increases 
in circulating leptin (current experiment), indicate that HC/HG diets can create unique 
metabolic and hormonal effects that distinguish them from both HF/LG and HF/HG 
diets.   Thus, further studies are warranted to integrate this information into a cohesive 
strategy for managing the pubertal process in heifers.  
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CHAPTER V 
 
SUMMARY AND CONCLUSIONS 
 
 Studies reported herein demonstrated that weaning heifers at approximately 3 
months of age and feeding two levels of dietary concentrate for 14 wk effects differential 
changes in gene expression within the ARC of the hypothalamus.  The three genes of 
interest, NPY, AGRP, and GHR, are of particular importance since they are thought to be 
involved in processes relaying metabolic signals to the central reproductive axis through 
neuronal pathways emanating from the within the ARC.  Our findings support previous 
studies demonstrating the involvement of NPY and AGRP in mediating pubertal 
development, as well reproductive cyclicity in mature animals.   In this context, there is 
strong evidence that both genes respond to metabolic signaling (leptin and insulin) by 
concurrently stimulating feeding behavior, suppressing the effects of POMC, and 
exerting inhibitory effects on the reproductive neuroendocrine axis.  Although the 
relationship between pubertal development and the decreased expression of GHR in the 
high-concentrate high-gain heifers is not as clear, previous reports indicate that GHR is 
localized in the majority of all NPY/AGRP neurons, and it appears that GH mediates the 
effects of NPY via the GHR.  Finally, our results suggest that IGF-1, insulin and leptin 
are likely involved in regulating expression of these genes, particularly since high-
concentrate high-gain heifers exhibited increased concentrations of all three hormones, 
and decreased expression of all three genes of interest.   
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 In the second experiment, although only a few heifers attained precocious 
puberty, it is clear that increased ADG during the juvenile period decreased the age at 
puberty.  The level of dietary concentrate did not appear to affect age at puberty; 
however, since only few animals attained precocious puberty, it is difficult to draw 
definitive conclusions regarding the role of this factor in precocious puberty.  It is 
possible that extending the dietary treatment period in the types of cattle used in our 
experiments would help clarify this issue.    The most striking observation in the second 
experiment appears to be the elevation in concentrations of leptin in HC/HG heifers 
during the 14-wk dietary treatment period.  Of equal importance is that after heifers were 
switched to the common growth diet, leptin decreased to concentrations similar to 
heifers in all other treatments during the 14-wk dietary treatment period.  It is possible 
that sustained increases in leptin signaling during the juvenile period that extend past 7 
months of age is necessary for accelerated maturation of the reproductive 
neuroendocrine axis.   In conclusion, we have demonstrated the ability to modify 
expression of a multitude of genes within the ARC by controlling intake, and feeding 
high- and low-concentrate diets during the juvenile period.  Furthermore, we have 
pinpointed three genes (NPY, AGRP, and GHR) previously demonstrated to be linked to 
metabolism and reproduction that were differentially expressed between dietary 
treatments.  As these genes are regulated by leptin and insulin, and it is possible that 
elevated leptin during the juvenile period, as demonstrated at slaughter in HC heifers 
(experiment 1) and in temporal concentrations in HC/HG heifers (experiment 2) may 
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modulate the expression of genes important for the metabolic control of puberty, such as 
NPY, AGRP, and GHR.   
Furthermore, it appears that, although heifers exhibit heightened sensitivity to 
dietary intake from 3-7 months of age, the period of time following 7 months of age may 
also contribute to the expression of precocious puberty in Bos indicus x Bos taurus 
heifers.  Since precocious puberty was not a prominent feature in Experiment 2, it is not 
possible to discern whether occurrence of the phenomenon is dependent upon a high-
concentrate diet.  Thus, further studies are warranted.   
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APPENDIX A 
PROCEDURES 
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Insulin-like Growth Factor-I Radioimmunoassay 
1. Iodination:  
Reference: Iodination grade r-hIGF-1 (R&D Systems Inc., Minneapolis, MN; Cat 
# 291-G1) 
 Reaction: 3 µg of hormone, 0.5 mCI of 125I, 3.5 µg Chloramine T, 60 sec, 
 22 µg Na-Metabisulfate 
2. Antibody: Polyclonal anti-human IGF-1 (rabbit anti-human IGF-1; LOT # 
NHPP) Dilution: 1:50,000 
3. Standards: r-hIGF-1 (R&D Systems Inc., Minneapolis, MN; Cat # 291-G1) 
Range: 0.156 – 10 ng/ml 
4. Reference preparation: CSS from cows with IGF-1 added in (see lab 
notebook/notes) 
5. RIA Procedure 
a) Label assay sheets and polypropylene tubes (IGF-1 sticks to glass) 
 4 NSB, 9 TC, 3 “0”, standards in triplicate, references in triplicate, and 
 unknown samples in triplicate 
b) Day 1: Extraction 
i) Pipette 50µl of unknown sample or references and 950 µl 0.2 M 
Glycylglycine Hydrochloride Solution into polypropylene extraction 
tubes 
ii) Vortex and place in room temperature water bath for 24 hr 
c) Day 2: Assay Procedure 
i) Remove extraction tubes from water bath, vortex, add 1 ml IGF-1 assay 
buffer, vortex and place in water bath for additional 6 hr 
ii) Following incubation, remove tubes from water bath, vortex  briefly 
and pipette the following: 
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  NSB: 400µl IGF-1 assay buffer 
  0 STD: 300µl IGF-1 assay buffer 
  STDs: 100µl STD + 200µl IGF-1 assay buffer 
  References: 100µl extracted reference + 200µl IGF-1 assay buffer 
  Unknowns: 100µl extracted sample + 200µl IGF-1 assay buffer  
  Vortex tubes and incubate overnight at 4o C (minimum time) 
d) Day 3:  Assay Procedure 
i) Pipette 100µl anti-IGF-1 primary antibody (diluted in IGF-1 assay buffer) 
into all except NSB and TC tubes and incubate for 1 hr at 4o C 
ii) Pipette 100µl 125I IGF-1 tracer (~20,000 cpm/tube; diluted in IGF-1 assay 
buffer) into all assay tubes, vortex, and incubate at 4o C for 16-24 hr 
iii) Prepare precipitated secondary antibody/NRS 
 Make 1:8 dilution of 2nd antibody (Who 30) in IGF-1 assay buffer 
 Make 1:150 dilution of NRS in IGF-1 assay buffer 
 Mix 2nd antibody and NRS solutions 1:1 and incubate overnight at 4o C  
e) Day 4: Secondary Antibody 
i) Finish 2nd antibody preparation 
ii) Briefly stir 2nd antibody/NRS solution and centrifuge for 30 min at 2900 
rpm at 4o C 
iii) Decant supernatant and bring back to original volume with new IGF-1 
assay buffer 
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iv) Pour buffer from each tube with pellet into a glass homogenizer and 
homogenize pellet into solution. Combine into one beaker after 
homogenizing 
v) Pipette 200µl of 2nd antibody/NRS solution into each assay tube, vortex 
and incubate at 4o C for 4 hr 
vi) Add 200µl 15% polyethylene glycol + 1 ml 0.01 M PBS into all tubes 
except TC tubes 
vii) Centrifuge tubes at 4o C for 45 min at 3600 rpm, decant supernatant (do 
not leave tubes upside down for more than 30 sec or pellet may slip) and 
count pellet on gamma counter 
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INSULIN RADIOIMMUNOASSAY 
Using Siemens Coat-A-Count Insulin RIA Kit 
 
References: 1) Accorsi PA, Govoni N, Pezzi C, Seren E, Taminini C. Reprod 
Dom Animal Leptin, GH, PRL, Insulin and Metabolic Parameters 
Throughout the Dry Period. 2005 40; 217-223 
  2) Siemens Healthcare Diagnostics Coat-A-Count Insulin Kit, 
Los Angeles, CA 
 
I. Assay Set Up 
A) Label assay sheet and number six (6) polypropylene test tubes  
(12 x 75 mm) as follows:     Tube #’s 
a) 4 Total Count (TC)     1-3 
b) 2 Non-specific Binding (NSB)    4-5 
B) Label lime green antibody coated tubes (supplied by the kit) for the:  
C) standards, references, and unknown samples in duplicate as follows: 
Tube #’s 
c) 3, 0 STD tubes      6-8 
d) Triplicate tubes for each of the following   9-35 
STD’s: 0.1, 0.2, 0.4, 0.6, 0.8, 1.0, 1.5, 2.0 and 2.5 ng/ml 
e) Duplicate tubes for the Low, Mid, and High references 36-41 
f) Duplicate tubes for the serum blank (CSS)  42-43 
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g) Duplicate tubes for each serum/plasma unknown  44- onward 
sample  
 
II. Assay Protocol (2 day assay) 
A) Pipette 200 µl of PBS-1% BSA into NSB and 0 standard tube 
B) Pipette 200 µl of each of the standards in triplicate 
C) Pipette 200 µl of each unknown sample, references and css in 
duplicate 
D) Pipette 1.0 ml of insulin tracer into every tube using the Eppendorf 
repeater pipettor with the insulin tip from the isotope room. Cover 
with aluminum foil and vortex briefly. 
 
NOTE: The 125I-insulin has to be at room temperature for at least 30 
minutes before dispensing into assay tubes. No more than 10 minutes 
should elapse during the dispensing of the tracer, to ensure equal 
incubation time for all the tubes. Therefore, run only 350 maximum in an 
assay to ensure a 10 minute dispense time for the tracer.  
E) Incubate for 18-24 hours at room temperature in the isotope room. 
F) After completion of incubation, transfer all tubes except total count 
tubes to Styrofoam racks and decant thoroughly into waste receptacle 
in the ISO lab hood. Strike or thump tubes sharply on adsorbent paper 
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to shake off all residual droplets. The bound insulin will stick to the 
insides of the antibody coated tube and will not be dislodged by the 
thumping. Be sure to remove all visible moisture from the tubes since 
this increases counting precision. 
G) Load tubes into gamma counter with insulin clip and press start. 
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Cresyl Violet Staining for bovine Hypothalamic Tissue Sections Fixed in 4% 
Paraformaldehyde 
I. Reagents and Materials 
1. 250 ml 4% Paraformaldehyde 
10 g Paraformaldehyde 
125 ml .2 M PB 
125 ml ddH20 
(Add paraformaldehyde with 125 ml .2 M PB and 50 ml ddH20, heat to 
approximately 65 C; add remaining ddH20 slowly until solution is 
dissolved) 
2. Cresyl Violet solution (filter before each use) 
3. Glacial Acetic Acid 
4. 70 %, 95 % and 100% Ethanol 
5. Acidified 70% Ethanol 
5 ml acetic acid 
245 ml 70% Ethanol 
6. 10X Acetate Buffer 
2.5 g Sodium Acetate (MW 136.08) 
  Dissolve in approximately 450 ml ddH20 
Adjust pH to 3.5 with glacial acetic acid (approximately 20 ml) 
Adjust final volume to 500 ml 
 
II. Procedure 
1. Air dry slides and place in 4% PAF for 15 minutes 
2. Dip twice in ddH20 
3. Place slides in 1X Acetate Buffer for 5 minutes 
4. Place slides in Cresyl Violet solution for 20-30 minutes 
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5. Dip twice in Acidified 70% Ethanol 
*Acidified 70% Ethanol should not be used for more than 2 racks 
 
6. Dehydrate sections through Ethanol as follows 
a) 70% EtOH- Dip three times 
b) 95% EtOH- Dip several time for 1 minute 
c) 100% EtOH for 5 minutes 
 
7. Place slides in Citrisolv 3 times for 5 minutes each 
8. Cover slip using DPX 
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RNA Isolation: RNAqueous®-Micro (Ambion) Protocol for Isolation of Small 
Quantities of RNA 
Fresh Frozen Sections on Slides 
Reagents and Materials 
RNAqueous®-Micro Kit 
1 Micro filter Cartridge Assembly/Sample 
1 Micro Elution Tube/Sample 
Wash Solution 1 (4 C; verify that 100% EtOH was added to the bottle) 
Wash Solution 2/3 (4 C; verify that 100% EtOH was added to the bottle 
Lysis Solution (4 C) 
DNase (-20 C) 
10X DNase I Buffer (-20 C) 
DNase Inactivation Reagent (-20 C) 
Elution Solution (4 C) 
 
Additional Materials 
1.5 ml Micro Centrifuge Tube/Sample 
5, 0.65 ml Micro Centrifuge Tubes/Sample 
100% Ethanol 
I. Preparation 
a) Label a Micro Filter Cartridge Assembly and Micro Elution Tube for 
each sample 
b) Aliquot 185 µl of Wash Solution 1 into .64 ml Micro Centrifuge Tube 
and warm to RT 
c) Aliquot 370 µl of Wash Solution 2/3 into .65 ml Micro Centrifuge Tube 
and warm to RT 
d) Heath aliquot (50µl per sample) of Elution Solution to 95 C on heat 
block 
e) Heat water back to 42 C 
 
II. Tissue Harvest 
a) Fill 1 ml syringe to 400µl (0.4 ml) with Lysis Solution 
b) Scrape appropriate tissue section with 25 gauge 5/8 needle 
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c) Transfer scraped tissue and small amount of Lysis Solution to 1.7 ml 
Micro Centrifuge Tube 
d) Repeat procedures b and c until desired amount of tissue is harvested 
e) Adjust volume in Micro Centrifuge tube to 400µl with remaining Lysis 
Solution 
f) Incubate sample for 30 min at 42 C; vortex briefly after 15 minutes of 
incubation 
g) Centrifuge for 30 sec to collect fluid at bottom of tube 
Remove 10 DNase I Buffer from -20̊C and thaw on ice 
 
III. Preparation of Micro Filter Cartridge Assembly and Lysate Mixture 
a) Add 30 µl of Lysis Solution to center of filter and allow to soak for ≥5 
minutes 
b) Add 3 µl of LCM Additive to Lysate Mixture and mix well by briefly 
vortexing 
c) Briefly centrifuge Lysate Mixture to collect the fluid at the bottom of the 
tube 
d) Add 200 µl of 100% Ethanol to Lysate Mixture tube* 
 
IV. Lysate Mixture Filtration 
a) Centrifuge Micro Filter Cartridge Assembly for 30 sec to remove Lysis 
Solution 
b) Load 150 µl Lysate/Ethanol mixture into prepared Micro Filter Cartridge 
assembly and close cap tightly** 
c) Centrifuge Lysate Mixture for 1 min at 10,000 x g 
d) Repeat steps b-d until all Lysate/ethanol mixture is passed through the 
filter 
 
V. Filter Wash 
a) Add 180 µl of Wash Solution 1 to the filter and close cap tightly 
b) Centrifuge for 1 min at 10,000 x g 
c) Add 180 µl of Wash Solution 2/3 to the filter and close cap tightly 
d) Centrifuge for 30 sec at 10,000 x g 
e) Repeat steps c and d with a second 180 µl aliquot of Wash Solution 
f) Remove Micro Filter Cartridge from the Collection Tube and discard 
flow-though liquid 
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g) Replace Filter, close cap and centrifuge assembly for 1 min to remove 
residual fluid and to dry filter 
 
VI. RNA Recovery 
a) Transfer Micro filter Cartridge from Collection Tube to Micro Elution 
Tube 
b) Add 10 µl of preheated (95 C) Elution Solution to center of filter 
c) Close cap and allow solution to sit for 5 min at RT 
d) Centrifuge assembly at 10,000 x g for 1 min to elute RNA from filter 
e) Repeat steps b-d with a second 10 µl aliquot of preheated Elution 
Solution collecting the elute in the same Elution Tube 
f) Pipette entire sample into a fresh DNase-free .65 ml Micro Centrifuge 
Tube 
 
VII. DNase I Treatment and DNase Inactivation 
a) Add 2 µl of 10X DNase Buffer and 1 µl of DNase to the sample and mix 
gently 
b) Incubate DNase reaction for 20 min 37  C (Remove DNase Inactivation 
Reagent from -20 C and allow to thaw at RT) 
c) Vortex DNase Inactivation Reagent vigorously to re-suspend slurry 
d) Add 2.2 µl of DNase Inactivation Reagent to reaction and incubate at RT 
for 2 min 
e) Vortex and incubate at RT for additional 1 min 
f) Centrifuge the reaction for 1.5 min at 10,000 x g  
g) Transfer 20 µl of RNA to a fresh DNase-free .65 Micro Centrifuge Tube 
and store at -80 C 
 
*Volume of 100% EtOH added is dependent on if you are recovering Large RNA 
Species, or Large and Small RNA Species. See RNAqueous®-Micro manual for 
additional information. 
 
**Caps on Collection Tubes and Elution Tubes tend to be stiff and can pop open. Bend 
back and forth to loosen hinge and make sure cap is on tight. 
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APPENDIX B 
IMAGES  
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Heifer 7585     Heifer 7589 
  
Heifer 7593     Heifer 7591 
126	  
	  
  
Heifer 7576     Heifer 7580 
  
Heifer 7584     Heifer 7586 
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Heifer 7587     Heifer 7583 
  
Heifer 7590     Heifer 7592 
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